April 2024
1. 
   Correction to: 2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Su
   Circulation. 2024;149:e1128.
   

   >> Share

   
   
2. GOLDFARB MJ, Saylor MA, Bozkurt B, Code J, et al
   Patient-Centered Adult Cardiovascular Care: A Scientific Statement From the American Heart Association.
   Circulation. 2024 Apr 11. doi: 10.1161/CIR.0000000000001233.
   

   >> Share

   
   
3. PATEL SM, Kang YM, Im K, Neuen BL, et al
   Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.
   Circulation. 2024 Apr 7. doi: 10.1161/CIRCULATIONAHA.124.069568.
   

   >> Share

   
   
4. FANAROFF AC, Patel MS, Chokshi N, Coratti S, et al
   Effect of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients at High Risk of Cardiovascular Events: The BE ACTIVE Randomized Controlled Trial.
   Circulation. 2024 Apr 7. doi: 10.1161/CIRCULATIONAHA.124.069531.
   

   >> Share

   
   
5. HERNANDEZ AF, Udell JA, Jones WS, Anker SD, et al
   Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights from the EMPACT-MI Trial.
   Circulation. 2024 Apr 6. doi: 10.1161/CIRCULATIONAHA.124.069217.
   

   >> Share

   
   
6. CHO L, Plutzky J, Brennan D, Louie MJ, et al
   Impact of Bempedoic Acid on Cardiovascular Outcomes by Sex.
   Circulation. 2024 Apr 6. doi: 10.1161/CIRCULATIONAHA.123.067691.
   

   >> Share

   
   
7. MAEHARA A, Sugizaki Y
   Intravascular Imaging for Guiding Percutaneous Coronary Intervention: What Does the Totality of Data Suggest, and Where Should We Go?
   Circulation. 2024;149:1087-1089.
   

   >> Share

   
   
8. BLUMER V, Kanwar MK, Barnett CF, Cowger JA, et al
   Cardiogenic Shock in Older Adults: A Focus on Age-Associated Risks and Approach to Management: A Scientific Statement From the American Heart Association.
   Circulation. 2024;149:e1051-e1065.
   

   >> Share

   
   
9. WU JC, Wilson BH, Fang JC, Hurwitz JL, et al
   Modernizing Cardiovascular Medicine Board Certification: Leveraging Innovation and Strengthening Continuous Competency and Professional Growth.
   Circulation. 2024 Apr 1. doi: 10.1161/CIRCULATIONAHA.124.069553.
   

   >> Share

   
   March 2024
10. BERG-HANSEN K, Gopalasingam N, Christensen KH, Ladefoged B, et al
    Cardiovascular Effects of Oral Ketone Ester Treatment in Patients With Heart Failure With Reduced Ejection Fraction: A Randomized, Controlled, Double-Blind Trial.
    Circulation. 2024 Mar 27. doi: 10.1161/CIRCULATIONAHA.123.067971.
    

    >> Share

    
    
11. LUSEBRINK E, Binzenhofer L, Hering D, Villegas Sierra L, et al
    Scrutinizing the Role of Venoarterial Extracorporeal Membrane Oxygenation: Has Clinical Practice Outpaced the Evidence?
    Circulation. 2024;149:1033-1052.
    

    >> Share

    
    
12. SERRUYS PW, Revaiah PC
    The American Heart Association's Centennial and Percutaneous Coronary Intervention's Semi-Centennial.
    Circulation. 2024;149:973-978.
    

    >> Share

    
    
13. FENG J, Li Y, Li Y, Yin Q, et al
    Versican Promotes Cardiomyocyte Proliferation and Cardiac Repair.
    Circulation. 2024;149:1004-1015.
    

    >> Share

    
    
14. 
    Correction to: Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association.
    Circulation. 2024;149:e1023.
    

    >> Share

    
    
15. SHUEY MM, Wang Y, Xiang RR, Zou A, et al
    Aggregation and Contextualization of Murine Investigations Improves Discovery of Significant Human Atherosclerotic Cardiovascular Disease Associations.
    Circulation. 2024;149:1056-1058.
    

    >> Share

    
    
16. TENG Z, Ma Y, Ma X
    Letter by Teng et al Regarding Article, "Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction".
    Circulation. 2024;149:e960-e961.
    

    >> Share

    
    
17. FRANGOGIANNIS NG
    Response by Frangogiannis to Letter Regarding Article, "Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction".
    Circulation. 2024;149:e962-e963.
    

    >> Share

    
    
18. MARANO P, Mouapi K, Kim A, Mastali M, et al
    Apolipoproteins Quantified Using Blood Volumetric Absorptive Microsampling and High-Throughput Mass Spectrometry for Risk Assessment in Ischemic Heart Disease.
    Circulation. 2024;149:970-972.
    

    >> Share

    
    
19. EVERETT BM
    The Confusing Landscape of Cardiovascular Health Assessment, Promotion, and Prediction.
    Circulation. 2024;149:914-916.
    

    >> Share

    
    
20. LANDSTROM AP, Chahal CAA, Roden DM, Ho CY, et al
    A Customizable and Peer-Reviewed Curriculum for Cardiovascular Genetics and Genomics.
    Circulation. 2024;149:902-904.
    

    >> Share

    
    
21. JUNCA G, Delgado V
    Dual (Ischemic and Nonischemic) Cardiomyopathy: A Wolf in Sheep's Clothing.
    Circulation. 2024;149:822-824.
    

    >> Share

    
    
22. HEUTS S, Myers PO, Siepe M
    Letter by Heuts et al Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
    Circulation. 2024;149:892-893.
    

    >> Share

    
    
23. RODRIGUEZ AE, Fernandez-Pereira C, Mieres J
    Letter by Rodriguez et al Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
    Circulation. 2024;149:894-895.
    

    >> Share

    
    
24. ZIMMERMANN FM, Ding VY, Fearon WF
    Response by Zimmermann et al to Letter Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
    Circulation. 2024;149:896.
    

    >> Share

    
    
25. HAYEK SS, Zaha VG, Bogle C, Deswal A, et al
    Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: From Pretransplantation to Survivorship: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Mar 11. doi: 10.1161/CIR.0000000000001220.
    

    >> Share

    
    
26. GABA P, Sabik JF, Murphy SA, Bellavia A, et al
    Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main Disease With or Without Diabetes: Findings From a Pooled Analysis of 4 Randomized Clinical Trials.
    Circulation. 2024 Mar 11. doi: 10.1161/CIRCULATIONAHA.123.065571.
    

    >> Share

    
    
27. ALEXANDER T, Kumbhani DJ, Mullasari Sankardas A
    The Future of Pharmacoinvasive Therapy for ST-Segment-Elevation Myocardial Infarction Reperfusion in the Post-STREAM Era.
    Circulation. 2024;149:732-733.
    

    >> Share

    
    
28. RAJAGOPALAN S, Brook RD
    Cardiovascular and Planetary Health: Two Sides of the Same Planet.
    Circulation. 2024;149:729-731.
    

    >> Share

    
    February 2024
29. CHEN Z, Zhang J, He Y
    Letter by Chen et al Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial".
    Circulation. 2024;149:725-726.
    

    >> Share

    
    
30. VAN DE WERF F, Sinnaeve P, Welsh RC, Armstrong PW, et al
    Response by Van de Werf et al to Letter Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial".
    Circulation. 2024;149:727-728.
    

    >> Share

    
    
31. GAFFEY AE, Rollman BL, Burg MM
    Strengthening the Pillars of Cardiovascular Health: Psychological Health is a Crucial Component.
    Circulation. 2024;149:641-643.
    

    >> Share

    
    
32. DZAU VJ, Hodgkinson CP
    RNA Therapeutics for the Cardiovascular System.
    Circulation. 2024;149:707-716.
    

    >> Share

    
    
33. YAN Y, Guo J, Wang X, Wang G, et al
    Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial.
    Circulation. 2024 Feb 26. doi: 10.1161/CIRCULATIONAHA.123.067079.
    

    >> Share

    
    
34. STOREY RF
    Antiplatelet Therapy After PCI: The Art and Science of De-Escalation.
    Circulation. 2024;149:601-604.
    

    >> Share

    
    
35. MOCUMBI AO
    Cardiovascular Health Care in Low- and Middle-Income Countries.
    Circulation. 2024;149:557-559.
    

    >> Share

    
    
36. LEWEY J, Beckie TM, Brown HL, Brown SD, et al
    Opportunities in the Postpartum Period to Reduce Cardiovascular Disease Risk After Adverse Pregnancy Outcomes: A Scientific Statement From the American Heart Association.
    Circulation. 2024;149:e330-e346.
    

    >> Share

    
    
37. BOEDDINGHAUS J, Doudesis D, Lopez-Ayala P, Lee KK, et al
    Machine Learning for Myocardial Infarction Compared With Guideline-Recommended Diagnostic Pathways.
    Circulation. 2024 Feb 12. doi: 10.1161/CIRCULATIONAHA.123.066917.
    

    >> Share

    
    
38. GIACOPPO D, Laudani C, Occhipinti G, Spagnolo M, et al
    Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography in the Guidance of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis.
    Circulation. 2024 Feb 12. doi: 10.1161/CIRCULATIONAHA.123.067583.
    

    >> Share

    
    
39. ELKIND MSV, Arnett DK, Benjamin IJ, Eckel RH, et al
    The American Heart Association at 100: A Century of Scientific Progress and the Future of Cardiovascular Science: A Presidential Advisory From the American Heart Association.
    Circulation. 2024 Feb 12. doi: 10.1161/CIR.0000000000001213.
    

    >> Share

    
    
40. GREEN JB, Everett BM, Ghosh A, Younes N, et al
    Cardiovascular Outcomes in GRADE (Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness Study).
    Circulation. 2024 Feb 12. doi: 10.1161/CIRCULATIONAHA.123.066604.
    

    >> Share

    
    January 2024
41. THURSTON RC, Chang Y, Kline CE, Swanson LM, et al
    Trajectories of Sleep Over Midlife and Incident Cardiovascular Disease Events in the Study of Women's Health Across the Nation.
    Circulation. 2024 Jan 29. doi: 10.1161/CIRCULATIONAHA.123.066491.
    

    >> Share

    
    
42. PETRIE MC, Rouleau JL, Claggett B, Jering K, et al
    Pulmonary Congestion and Left Ventricular Dysfunction After Myocardial Infarction: Insights From the PARADISE-MI Trial.
    Circulation. 2024;149:335-338.
    

    >> Share

    
    
43. MERCHANT RM, Becker LB, Brooks SC, Chan PS, et al
    The American Heart Association Emergency Cardiovascular Care 2030 Impact Goals and Call to Action to Improve Cardiac Arrest Outcomes: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Jan 22. doi: 10.1161/CIR.0000000000001196.
    

    >> Share

    
    
44. SUN M, Mao S, Wu C, Zhao X, et al
    Piezo1-Mediated Neurogenic Inflammatory Cascade Exacerbates Ventricular Remodeling After Myocardial Infarction.
    Circulation. 2024 Jan 18. doi: 10.1161/CIRCULATIONAHA.123.065390.
    

    >> Share

    
    
45. SHEEHY S, Brock M, Palmer JR, Albert MA, et al
    Perceived Interpersonal Racism in Relation to Incident Coronary Heart Disease Among Black Women.
    Circulation. 2024 Jan 18. doi: 10.1161/CIRCULATIONAHA.123.066471.
    

    >> Share

    
    
46. ONNIS C, Virmani R, Kawai K, Nardi V, et al
    Coronary Artery Calcification: Current Concepts and Clinical Implications.
    Circulation. 2024;149:251-266.
    

    >> Share

    
    
47. SAYOLS-BAIXERAS S, Dekkers KF, Orho-Melander M, Fall T, et al
    Response by Sayols-Baixeras et al to Letter Regarding Article, "Streptococcus Species Abundance in the Gut Is Linked to Subclinical Coronary Atherosclerosis in 8973 Participants From the SCAPIS Cohort".
    Circulation. 2024;149:276.
    

    >> Share

    
    
48. LI G, Chen H, Ren C, Yang Z, et al
    Letter by Li et al Regarding Article, "Streptococcus Species Abundance in the Gut Is Linked to Subclinical Coronary Atherosclerosis in 8973 Participants From the SCAPIS Cohort".
    Circulation. 2024;149:274-275.
    

    >> Share

    
    
49. HANNEMAN K, Playford D, Dey D, van Assen M, et al
    Value Creation Through Artificial Intelligence and Cardiovascular Imaging: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Jan 9. doi: 10.1161/CIR.0000000000001202.
    

    >> Share

    
    
50. CULIC V
    Letter by Culic Regarding Article, "Extreme Temperature Events, Fine Particulate Matter, and Myocardial Infarction Mortality".
    Circulation. 2024;149:167.
    

    >> Share

    
    
51. XU R, Huang S, Wei J, Sun H, et al
    Response by Xu et al to Letter Regarding Article, "Extreme Temperature Events, Fine Particulate Matter, and Myocardial Infarction Mortality".
    Circulation. 2024;149:168-169.
    

    >> Share

    
    
52. TAQUETI VR
    Prevalence of Abnormal Coronary Function in Patients With Angina and No Obstructive Coronary Artery Disease on Coronary Computed Tomography Angiography: Insights From the CorCTA Trial.
    Circulation. 2024;149:24-27.
    

    >> Share

    
    
53. SINHA A, Rahman H, Douiri A, Demir OM, et al
    ChaMP-CMD: A Phenotype-Blinded, Randomized Controlled, Cross-Over Trial.
    Circulation. 2024;149:36-47.
    

    >> Share

    
    December 2023
54. PRAPIADOU S, Zivkovic L, Thorand B, George MJ, et al
    Proteogenomic Data Integration Reveals CXCL10 as a Potentially Downstream Causal Mediator for IL-6 Signaling on Atherosclerosis.
    Circulation. 2023 Dec 28. doi: 10.1161/CIRCULATIONAHA.123.064974.
    

    >> Share

    
    
55. KUEHN BM
    Initiatives Aim to Help Mitigate Cardiovascular Risks of Extreme Temperatures.
    Circulation. 2023;148:2064-2066.
    

    >> Share

    
    
56. PERMAN SM, Elmer J, Maciel CB, Uzendu A, et al
    2023 American Heart Association Focused Update on Adult Advanced Cardiovascular Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2023 Dec 18. doi: 10.1161/CIR.0000000000001194.
    

    >> Share

    
    
57. GALLAGHER KA, Mills JL, Armstrong DG, Conte MS, et al
    Current Status and Principles for the Treatment and Prevention of Diabetic Foot Ulcers in the Cardiovascular Patient Population: A Scientific Statement From the American Heart Association.
    Circulation. 2023 Dec 14. doi: 10.1161/CIR.0000000000001192.
    

    >> Share

    
    
58. VAN DUIJVENBODEN S, Ramirez J, Orini M, Aung N, et al
    Prognostic Significance of Different Ventricular Ectopic Burdens During Submaximal Exercise in Asymptomatic UK Biobank Subjects.
    Circulation. 2023;148:1932-1944.
    

    >> Share

    
    
59. PALUCH AE, Boyer WR, Franklin BA, Laddu D, et al
    Resistance Exercise Training in Individuals With and Without Cardiovascular Disease: 2023 Update: A Scientific Statement From the American Heart Association.
    Circulation. 2023 Dec 7. doi: 10.1161/CIR.0000000000001189.
    

    >> Share

    
    
60. 
    Correction to: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
    Circulation. 2023;148:e186.
    

    >> Share

    
    
61. LAGUZZI F, Akesson A, Marklund M, Qian F, et al
    Role of Polyunsaturated Fat in Modifying Cardiovascular Risk Associated With Family History of Cardiovascular Disease: Pooled De Novo Results From 15 Observational Studies.
    Circulation. 2023 Dec 4. doi: 10.1161/CIRCULATIONAHA.123.065530.
    

    >> Share

    
    
62. BADDOUR LM, Esquer Garrigos Z, Rizwan Sohail M, Havers-Borgersen E, et al
    Update on Cardiovascular Implantable Electronic Device Infections and Their Prevention, Diagnosis, and Management: A Scientific Statement From the American Heart Association.
    Circulation. 2023 Dec 4. doi: 10.1161/CIR.0000000000001187.
    

    >> Share

    
    November 2023
63. HUNDEMER GL, Agharazii M, Madore F, Vaidya A, et al
    Subclinical Primary Aldosteronism and Cardiovascular Health: A Population-Based Cohort Study.
    Circulation. 2023 Nov 30. doi: 10.1161/CIRCULATIONAHA.123.066389.
    

    >> Share

    
    
64. WU F, Juonala M, Jacobs DR Jr, Daniels SR, et al
    Childhood Non-HDL Cholesterol and LDL Cholesterol and Adult Atherosclerotic Cardiovascular Events.
    Circulation. 2023 Nov 28. doi: 10.1161/CIRCULATIONAHA.123.064296.
    

    >> Share

    
    
65. NATSUAKI M, Watanabe H, Morimoto T, Yamamoto K, et al
    An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial.
    Circulation. 2023 Nov 23. doi: 10.1161/CIRCULATIONAHA.123.066720.
    

    >> Share

    
    
66. YAMADA NK, Szyld E, Strand ML, Finan E, et al
    2023 American Heart Association and American Academy of Pediatrics Focused Update on Neonatal Resuscitation: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2023 Nov 16. doi: 10.1161/CIR.0000000000001181.
    

    >> Share

    
    
67. KIM MC, Lim Y, Lee SH, Shin Y, et al
    Early Left Ventricular Unloading or Conventional Approach After Venoarterial Extracorporeal Membrane Oxygenation: The EARLY-UNLOAD Randomized Clinical Trial.
    Circulation. 2023;148:1570-1581.
    

    >> Share

    
    
68. NEUEN BL, Heerspink HJL, Vart P, Claggett BL, et al
    Estimated Lifetime Cardiovascular, Kidney and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Non-steroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria.
    Circulation. 2023 Nov 12. doi: 10.1161/CIRCULATIONAHA.123.067584.
    

    >> Share

    
    
69. PATEL KV, Segar MW, Klonoff DC, Khan MS, et al
    Optimal Screening for Predicting and Preventing the Risk of Heart Failure Among Adults With Diabetes Without Atherosclerotic Cardiovascular Disease: a Pooled Cohort Analysis.
    Circulation. 2023 Nov 11. doi: 10.1161/CIRCULATIONAHA.123.067530.
    

    >> Share

    
    
70. KHAN SS, Coresh J, Pencina MJ, Ndumele CE, et al
    Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association.
    Circulation. 2023 Nov 10. doi: 10.1161/CIR.0000000000001191.
    

    >> Share

    
    
71. KHAN SS, Matsushita K, Sang Y, Ballew SH, et al
    Development and Validation of the American Heart Association Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Equations.
    Circulation. 2023 Nov 10. doi: 10.1161/CIRCULATIONAHA.123.067626.
    

    >> Share

    
    
72. BERG KM, Bray JE, Ng KC, Liley HG, et al
    2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Educatio
    Circulation. 2023 Nov 9. doi: 10.1161/CIR.0000000000001179.
    

    >> Share

    
    
73. GAO L, Zhao Y, Wu H, Lin X, et al
    Polycystic Ovary Syndrome Fuels Cardiovascular Inflammation and Aggravates Ischemic Cardiac Injury.
    Circulation. 2023 Nov 8. doi: 10.1161/CIRCULATIONAHA.123.065827.
    

    >> Share

    
    
74. LI S, Qian J, Li JJ
    Letter by Li et al Regarding Article, "Severe Infection and Risk of Cardiovascular Disease: A Multicohort Study".
    Circulation. 2023;148:1507-1508.
    

    >> Share

    
    
75. OGAH OS, Orimolade OA, Jinadu TO
    Cardiovascular Diseases in Nigeria: Current Status, Threats, and Opportunities.
    Circulation. 2023;148:1441-1444.
    

    >> Share

    
    
76. SIPILA PN, Kivimaki M
    Response by Sipila and Kivimaki to Letter Regarding Article, "Severe Infection and Risk of Cardiovascular Disease: A Multicohort Study".
    Circulation. 2023;148:1509-1510.
    

    >> Share

    
    
77. RIDKER PM, Lei L, Louie MJ, Haddad T, et al
    Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13970 Contemporary High-Risk Patients With Statin Intolerance.
    Circulation. 2023 Nov 6. doi: 10.1161/CIRCULATIONAHA.123.066213.
    

    >> Share

    
    
78. BAWASKAR P, Thomas N, Ismail KF, Guo Y, et al
    Non-ischemic or Dual Cardiomyopathy in Patients with Coronary Artery Disease.
    Circulation. 2023 Nov 6. doi: 10.1161/CIRCULATIONAHA.123.067032.
    

    >> Share

    
    October 2023
79. CHENG YC, Hsieh ML, Lin CJ, Chang CMC, et al
    Combined Treatment of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Endothelial Cells Regenerate the Infarcted Heart in Mice and Non-Human Primates.
    Circulation. 2023;148:1395-1409.
    

    >> Share

    
    
80. KHATANA SAM, Eberly LA, Nathan AS, Groeneveld PW, et al
    Projected Change in the Burden of Excess Cardiovascular Deaths Associated With Extreme Heat by Midcentury (2036-2065) in the Contiguous United States.
    Circulation. 2023 Oct 30. doi: 10.1161/CIRCULATIONAHA.123.066017.
    

    >> Share

    
    
81. HONG SJ, Lee SJ, Suh Y, Yun KH, et al
    Stopping Aspirin Within 1 Month After Stenting for Ticagrelor Monotherapy in Acute Coronary Syndrome: The T-PASS Randomized Noninferiority Trial.
    Circulation. 2023 Oct 25. doi: 10.1161/CIRCULATIONAHA.123.066943.
    

    >> Share

    
    
82. GLENN AJ, Guasch-Ferre M, Malik VS, Kendall CWC, et al
    Portfolio Diet Score and Risk of Cardiovascular Disease: Findings From 3 Prospective Cohort Studies.
    Circulation. 2023 Oct 25. doi: 10.1161/CIRCULATIONAHA.123.065551.
    

    >> Share

    
    
83. RUEL M, Fischbein MP, de Lemos JA
    Introduction to the 2023 Cardiovascular Surgery Issue.
    Circulation. 2023;148:1287-1288.
    

    >> Share

    
    
84. HU Z, Wang C, Yuan X, Zhang S, et al
    Potential of Quantitative Flow Ratio for Selecting Target Vessels for Radial Artery Grafting: A Retrospective Observational Study.
    Circulation. 2023;148:1340-1342.
    

    >> Share

    
    
85. BABER U, Jang Y, Oliva A, Cao D, et al
    Safety and Efficacy of Ticagrelor Monotherapy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: an Individual Patient Data Meta-analysis of TWILIGHT and TICO Randomized Trials.
    Circulation. 2023 Oct 23. doi: 10.1161/CIRCULATIONAHA.123.067283.
    

    >> Share

    
    
86. RAYCHEV R, Sun JL, Schwamm L, Smith EE, et al
    Performance of Thrombectomy-Capable, Comprehensive, and Primary Stroke Centers in Reperfusion Therapies for Acute Ischemic Stroke: Report From the Get With The Guidelines-Stroke Registry.
    Circulation. 2023 Oct 19. doi: 10.1161/CIRCULATIONAHA.123.066114.
    

    >> Share

    
    
87. RYMER J, Anand SS, Sebastian Debus E, Haskell LP, et al
    Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD.
    Circulation. 2023 Oct 18. doi: 10.1161/CIRCULATIONAHA.122.063806.
    

    >> Share

    
    
88. BIKDELI B, Erlinge D, Valgimigli M, Kastrati A, et al
    Bivalirudin Versus Heparin During PCI in NSTEMI: Individual Patient Data Meta-Analysis of Large Randomized Trials.
    Circulation. 2023;148:1207-1219.
    

    >> Share

    
    
89. HOWARD G, Cushman M, Blair J, Wilson NR, et al
    Comparative Discrimination of Life's Simple 7 and Life's Essential 8 to Stratify Cardiovascular Risk: Is the Added Complexity Worth It?
    Circulation. 2023 Oct 13. doi: 10.1161/CIRCULATIONAHA.123.065472.
    

    >> Share

    
    
90. NDUMELE CE, Rangaswami J, Chow SL, Neeland IJ, et al
    Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association.
    Circulation. 2023 Oct 9. doi: 10.1161/CIR.0000000000001184.
    

    >> Share

    
    
91. NDUMELE CE, Neeland IJ, Tuttle KR, Chow SL, et al
    A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association.
    Circulation. 2023 Oct 9. doi: 10.1161/CIR.0000000000001186.
    

    >> Share

    
    
92. SIDIK NP, Stanley B, Sykes R, Morrow AJ, et al
    Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled Trial.
    Circulation. 2023 Oct 5. doi: 10.1161/CIRCULATIONAHA.123.064751.
    

    >> Share

    
    
93. KIM JM, Stern RM, Maron BA
    Bleeding and Myocardial Infarction in Acquired Factor VIII Deficiency.
    Circulation. 2023;148:1127-1133.
    

    >> Share

    
    
94. RIDKER PM
    The Time to Initiate Anti-Inflammatory Therapy for Patients With Chronic Coronary Atherosclerosis Has Arrived.
    Circulation. 2023;148:1071-1073.
    

    >> Share

    
    
95. WAKSMAN R, Pahuja M, van Diepen S, Proudfoot AG, et al
    Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC).
    Circulation. 2023;148:1113-1126.
    

    >> Share

    
    
96. ZHOU H, Yang J, Srinath C, Zeng A, et al
    Improved Cardiac Function in Postischemic Rats Using an Optimized Cardiac Reprogramming Cocktail Delivered in a Single Novel Adeno-Associated Virus.
    Circulation. 2023;148:1099-1112.
    

    >> Share

    
    
97. WADHERA RK
    Value-Based Payment for Cardiovascular Care: Getting to the Heart of the Matter.
    Circulation. 2023;148:1084-1086.
    

    >> Share

    
    September 2023
98. JONES DA, Beirne AM, Kelham M, Rathod KS, et al
    Computed Tomography Cardiac Angiography Before Invasive Coronary Angiography in Patients With Previous Bypass Surgery: The BYPASS-CTCA Trial.
    Circulation. 2023 Sep 29. doi: 10.1161/CIRCULATIONAHA.123.064465.
    

    >> Share

    
    
99. 
    Correction to: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
    Circulation. 2023;148:e148.
    

    >> Share

    
    
100. ALDANA-BITAR J, Karlsberg RP, Budoff MJ
     Letter by Aldana-Bitar et al Regarding Article, "Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients With Familial Hypercholesterolemia: The ARCHITECT Study".
     Circulation. 2023;148:1057.
     

     >> Share

     
     
101. PEREZ DE ISLA L, Saltijeral Cerezo A, Mata P
     Response by Perez de Isla et al to Letter Regarding Article, "Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients With Familial Hypercholesterolemia: The ARCHITECT Study".
     Circulation. 2023;148:1059-1060.
     

     >> Share

     
     
102. LONG X, Jiang M
     Letter by Long and Jiang Regarding Article, "Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients With Familial Hypercholesterolemia: The ARCHITECT Study".
     Circulation. 2023;148:1058.
     

     >> Share

     
     
103. VALGIMIGLI M, Wlodarczak A, Tolg R, Merkely B, et al
     Biodegradable-Polymer or Durable-Polymer Stents in Patients at High Bleeding Risk: A Randomized, Open-Label Clinical Trial.
     Circulation. 2023;148:989-999.
     

     >> Share

     
     
104. GODFREY S, Kirkpatrick JN, Kramer DB, Sulistio MS, et al
     Expanding the Paradigm for Cardiovascular Palliative Care.
     Circulation. 2023;148:1039-1052.
     

     >> Share

     
     
105. ADDISON D, Neilan TG, Barac A, Scherrer-Crosbie M, et al
     Cardiovascular Imaging in Contemporary Cardio-Oncology: A Scientific Statement From the American Heart Association.
     Circulation. 2023 Sep 21. doi: 10.1161/CIR.0000000000001174.
     

     >> Share

     
     
106. CHOI DY, Hayes D, Maidman SD, Dhaduk N, et al
     Existing Nongated CT Coronary Calcium Predicts Operative Risk in Patients Undergoing Noncardiac Surgeries (ENCORES).
     Circulation. 2023 Sep 21. doi: 10.1161/CIRCULATIONAHA.123.064398.
     

     >> Share

     
     
107. LAVONAS EJ, Akpunonu PD, Arens AM, Babu KM, et al
     2023 American Heart Association Focused Update on the Management of Patients With Cardiac Arrest or Life-Threatening Toxicity Due to Poisoning: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Card
     Circulation. 2023 Sep 18. doi: 10.1161/CIR.0000000000001161.
     

     >> Share

     
     
108. MOORE-MORRIS T, Evans SM
     Cardiac Pericyte Diversity in Infarct Remodeling: Not Just Vascular Support Cells?
     Circulation. 2023;148:899-902.
     

     >> Share

     
     
109. AGARWALA A, Patel J, Stephens J, Roberson S, et al
     Implementation of Prevention Science to Eliminate Health Care Inequities in Achieving Cardiovascular Health: A Scientific Statement From the American Heart Association.
     Circulation. 2023 Sep 12. doi: 10.1161/CIR.0000000000001171.
     

     >> Share

     
     
110. HONG D, Kim SM, Lee SY, Choi KH, et al
     Prognostic Impact of Intravascular Imaging-Guided Percutaneous Coronary Intervention in Chronic Total Occlusion.
     Circulation. 2023;148:903-905.
     

     >> Share

     
     
111. SHASHIKUMAR SA, Zheng J, Orav EJ, Epstein AM, et al
     Changes in Cardiovascular Spending, Care Utilization, and Clinical Outcomes Associated With Participation in Bundled Payments for Care Improvement Advanced.
     Circulation. 2023 Sep 8. doi: 10.1161/CIRCULATIONAHA.123.065109.
     

     >> Share

     
     August 2023
112. OSTADAL P, Belohlavek J
     Response by Ostadal and Belohlavek to Letter Regarding Article, "Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Results of the ECMO-CS Randomized Clinical Trial".
     Circulation. 2023;148:804.
     

     >> Share

     
     
113. FERREIRA J
     Letter by Ferreira Regarding Article, "Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Results of the ECMO-CS Randomized Clinical Trial".
     Circulation. 2023;148:803.
     

     >> Share

     
     
114. KANG DY, Ahn JM, Yun SC, Hur SH, et al
     Optical Coherence Tomography-Guided or Intravascular Ultrasound Guided Percutaneous Coronary Intervention: The OCTIVUS Randomized Clinical Trial.
     Circulation. 2023 Aug 27. doi: 10.1161/CIRCULATIONAHA.123.066429.
     

     >> Share

     
     
115. SZAREK M, Reijnders E, Jukema JW, Bhatt DL, et al
     Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of Three Tests.
     Circulation. 2023 Aug 26. doi: 10.1161/CIRCULATIONAHA.123.066398.
     

     >> Share

     
     
116. ZIMMERMANN FM, Ding VY, Pijls NHJ, Piroth Z, et al
     Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial.
     Circulation. 2023 Aug 21. doi: 10.1161/CIRCULATIONAHA.123.065770.
     

     >> Share

     
     
117. WANG Z, Du X, Hua C, Li W, et al
     The Effect of Frailty on the Efficacy and Safety of Intensive Blood Pressure Control: A Post Hoc Analysis of the SPRINT Trial.
     Circulation. 2023;148:565-574.
     

     >> Share

     
     
118. DENNISON HIMMELFARB CR, Beckie TM, Allen LA, Commodore-Mensah Y, et al
     Shared Decision-Making and Cardiovascular Health: A Scientific Statement From the American Heart Association.
     Circulation. 2023 Aug 14. doi: 10.1161/CIR.0000000000001162.
     

     >> Share

     
     
119. CAINZOS-ACHIRICA M
     Letter by Cainzos-Achirica Regarding Article, "Incidental Coronary Artery Calcium: Opportunistic Screening of Previous Nongated Chest Computed Tomography Scans to Improve Statin Rates (NOTIFY-1 Project)".
     Circulation. 2023;148:440.
     

     >> Share

     
     
120. SANDHU AT, Rodriguez F, Maron DJ
     Response by Sandhu et al to Letter Regarding Article, "Incidental Coronary Artery Calcium: Opportunistic Screening of Previous Nongated Chest Computed Tomography Scans to Improve Statin Rates (NOTIFY-1 Project)".
     Circulation. 2023;148:441.
     

     >> Share

     
     
121. YU CK, Tsao S, Ng CW, Chua GT, et al
     Cardiovascular Assessment up to One Year After COVID-19 Vaccine-Associated Myocarditis.
     Circulation. 2023;148:436-439.
     

     >> Share

     
     July 2023
122. XU R, Huang S, Shi C, Wang R, et al
     Extreme Temperature Events, Fine Particulate Matter, and Myocardial Infarction Mortality.
     Circulation. 2023;148:312-323.
     

     >> Share

     
     
123. KHATANA SAM, Groeneveld PW
     Extreme Heat and Poor Air Quality: Dual Threats to Cardiovascular Health.
     Circulation. 2023;148:324-326.
     

     >> Share

     
     
124. YIN ZW, Duan J
     Exercise-Induced Chest Pain: Ischemia or Something Else.
     Circulation. 2023;148:373-374.
     

     >> Share

     
     
125. VIRANI SS, Newby LK, Arnold SV, Bittner V, et al
     2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
     Circulation. 2023 Jul 20. doi: 10.1161/CIR.0000000000001168.
     

     >> Share

     
     
126. RAO SV, Reynolds HR, Hochman JS
     Chronic Coronary Disease Guidelines.
     Circulation. 2023 Jul 20. doi: 10.1161/CIRCULATIONAHA.123.064623.
     

     >> Share

     
     
127. OSHO A, Fernandes MF, Poudel R, de Lemos J, et al
     Race-Based Differences in ST-Segment-Elevation Myocardial Infarction Process Metrics and Mortality From 2015 Through 2021: An Analysis of 178 062 Patients From the American Heart Association Get With The Guidelines-Coronary Artery Disease Registry.
     Circulation. 2023;148:229-240.
     

     >> Share

     
     
128. OHM J, Kuja-Halkola R, Warnqvist A, Habel H, et al
     Socioeconomic Disparities and Mediators for Recurrent Atherosclerotic Cardiovascular Disease Events After a First Myocardial Infarction.
     Circulation. 2023;148:256-267.
     

     >> Share

     
     
129. LAGU T, Schroth SL, Haywood C, Heinemann A, et al
     Diagnosis and Management of Cardiovascular Risk in Individuals With Spinal Cord Injury: A Narrative Review.
     Circulation. 2023;148:268-277.
     

     >> Share

     
     
130. HENDERSON KH, Hammond RA, Homer JB
     Complex Adaptive Systems Simulation Modeling to Address Cardiovascular Disparities: Complex Science for a Complex Problem.
     Circulation. 2023;148:201-203.
     

     >> Share

     
     
131. DIXON DD, Wilkins CH
     Strategies to Cultivate Diversity and Achieve Equity in Cardiovascular Clinical Trials.
     Circulation. 2023;148:204-206.
     

     >> Share

     
     
132. WADHERA RK, Watson KE, Carnethon MR
     Advancing Cardiovascular Health Equity in the United States: Now That We Know, Where Do We Go Next?
     Circulation. 2023;148:197-198.
     

     >> Share

     
     
133. AL-KINDI S, Motairek I, Kreatsoulas C, Wright JT Jr, et al
     Historical Neighborhood Redlining and Cardiovascular Risk in Patients With Chronic Kidney Disease.
     Circulation. 2023;148:280-282.
     

     >> Share

     
     
134. VAN DE WERF F, Ristic AD, Averkov OV, AriasMendoza A, et al
     Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction in STREAM-2: A Randomized, Open-Label Trial.
     Circulation. 2023 Jul 13. doi: 10.1161/CIRCULATIONAHA.123.064521.
     

     >> Share

     
     
135. SAYOLS-BAIXERAS S, Dekkers KF, Baldanzi G, Jonsson D, et al
     Streptococcus Species Abundance in the Gut Is Linked to Subclinical Coronary Atherosclerosis in 8973 Participants From the SCAPIS Cohort.
     Circulation. 2023 Jul 12. doi: 10.1161/CIRCULATIONAHA.123.063914.
     

     >> Share

     
     
136. TENG Z, Ma X, Ma Y
     Letter by Teng et al Regarding Article, "Direct Reprogramming Improves Cardiac Function and Reverses Fibrosis in Chronic Myocardial Infarction".
     Circulation. 2023;148:170-171.
     

     >> Share

     
     
137. SADAHIRO T, Tani H, Ieda M
     Response by Sadahiro et al to Letter Regarding Article, "Direct Reprogramming Improves Cardiac Function and Reverses Fibrosis in Chronic Myocardial Infarction".
     Circulation. 2023;148:172-173.
     

     >> Share

     
     
138. SANDHU AT, Heidenreich PA, Borden W, Farmer SA, et al
     Value-Based Payment for Clinicians Treating Cardiovascular Disease: A Policy Statement From the American Heart Association.
     Circulation. 2023 Jul 10. doi: 10.1161/CIR.0000000000001143.
     

     >> Share

     
     
139. ROSSI LP, Granger BB, Bruckel JT, Crabbe DL, et al
     Person-Centered Models for Cardiovascular Care: A Review of the Evidence: A Scientific Statement From the American Heart Association.
     Circulation. 2023 Jul 10. doi: 10.1161/CIR.0000000000001141.
     

     >> Share

     
     
140. GAUDINO M, Sandner S, An KR, Dimagli A, et al
     Graft Failure After Coronary Artery Bypass Grafting and Its Association With Patient Characteristics and Clinical Events: A Pooled Individual Patient Data Analysis of Clinical Trials With Imaging Follow-Up.
     Circulation. 2023 Jul 7. doi: 10.1161/CIRCULATIONAHA.123.064090.
     

     >> Share

     
     
141. MCEVOY JW, Wang D, Brady T, Tang O, et al
     Myocardial Injury Thresholds for 4 High-Sensitivity Troponin Assays in a Population-Based Sample of US Children and Adolescents.
     Circulation. 2023;148:7-16.
     

     >> Share

     
     June 2023
142. ALEX L, Tuleta I, Hernandez SC, Hanna A, et al
     Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction.
     Circulation. 2023 Jun 23. doi: 10.1161/CIRCULATIONAHA.123.064155.
     

     >> Share

     
     
143. GAUDINO M, Dangas GD, Angiolillo DJ, Brodt J, et al
     Considerations on the Management of Acute Postoperative Ischemia After Cardiac Surgery: A Scientific Statement From the American Heart Association.
     Circulation. 2023 Jun 22. doi: 10.1161/CIR.0000000000001154.
     

     >> Share

     
     
144. CAPODANNO D, Mehran R, Krucoff MW, Baber U, et al
     Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium.
     Circulation. 2023;147:1933-1944.
     

     >> Share

     
     
145. MOIZ A, Eisenberg MJ
     Initiation of Varenicline in People Hospitalized for Acute Coronary Syndrome Who Smoke.
     Circulation. 2023;147:1869-1871.
     

     >> Share

     
     
146. OZKAN B, Ndumele CE
     Addressing Cardiovascular Risk in Diabetes: It's More Than the Sugar.
     Circulation. 2023;147:1887-1890.
     

     >> Share

     
     
147. AJUFO E, Channaoui N, Marston N
     Absorbing Account of Premature Myocardial Infarction.
     Circulation. 2023;147:1843-1847.
     

     >> Share

     
     
148. HOFMANN R, Back M
     Time for Routine Helicobacter pylori Screening in Coronary Artery Disease?
     Circulation. 2023;147:1731-1733.
     

     >> Share

     
     May 2023
149. SINHA SS, Katz JN, Morrow DA
     Cultivating the Research Landscape for Critical Care Cardiology: The Case for Registry-Based Randomized Controlled Trials.
     Circulation. 2023;147:1637-1639.
     

     >> Share

     
     
150. JEROME GJ, Boyer WR, Bustamante EE, Kariuki J, et al
     Increasing Equity of Physical Activity Promotion for Optimal Cardiovascular Health in Adults: A Scientific Statement From the American Heart Association.
     Circulation. 2023 May 24. doi: 10.1161/CIR.0000000000001148.
     

     >> Share

     
     
151. DALZELL JR
     Issues With the Design of Randomized Trials of Temporary Mechanical Circulatory Support for Cardiogenic Shock.
     Circulation. 2023;147:1489-1491.
     

     >> Share

     
     
152. ZHANG Y, Dron JS, Bellows BK, Khera AV, et al
     Association of Severe Hypercholesterolemia and Familial Hypercholesterolemia Genotype With Risk of Coronary Heart Disease.
     Circulation. 2023;147:1556-1559.
     

     >> Share

     
     
153. DAMLUJI AA, Alfaraidhy M, AlHajri N, Rohant NN, et al
     Sarcopenia and Cardiovascular Diseases.
     Circulation. 2023;147:1534-1553.
     

     >> Share

     
     
154. KWAN TW, Wong SS, Hong Y, Kanaya AM, et al
     Epidemiology of Diabetes and Atherosclerotic Cardiovascular Disease Among Asian American Adults: Implications, Management, and Future Directions: A Scientific Statement From the American Heart Association.
     Circulation. 2023 May 8. doi: 10.1161/CIR.0000000000001145.
     

     >> Share

     
     
155. SATTAR N, McMurray J, Boren J, Rawshani A, et al
     Years of Cardiovascular Complications and Risk Factors in Patients With Type 2 Diabetes: A Nationwide Swedish Cohort Study.
     Circulation. 2023 May 8. doi: 10.1161/CIRCULATIONAHA.122.063374.
     

     >> Share

     
     April 2023
156. DE BAKKER M, Anand A, Shipley M, Fujisawa T, et al
     Sex Differences in Cardiac Troponin Trajectories Over the Life Course.
     Circulation. 2023 Apr 28. doi: 10.1161/CIRCULATIONAHA.123.064386.
     

     >> Share

     
     
157. GIBSON WO, McEvoy JW
     Letter by Gibson and McEvoy Regarding Article, "Influence of Age on the Diagnosis of Myocardial Infarction".
     Circulation. 2023;147:1312-1313.
     

     >> Share

     
     
158. LOWRY MTH, Mills NL, Anand A
     Response by Lowry et al to Letter Regarding Article, "Influence of Age on the Diagnosis of Myocardial Infarction".
     Circulation. 2023;147:1315-1316.
     

     >> Share

     
     
159. CHEN T, Xu X, Zhu H
     Letter by Chen et al Regarding Article, "Influence of Age on the Diagnosis of Myocardial Infarction".
     Circulation. 2023;147:1314.
     

     >> Share

     
     
160. SAMAD Z, Hanif B
     Cardiovascular Diseases in Pakistan: Imagining a Postpandemic, Postconflict Future.
     Circulation. 2023;147:1261-1263.
     

     >> Share

     
     
161. EZAD SM, Ryan M, Donker DW, Pappalardo F, et al
     Unloading the Left Ventricle in Venoarterial ECMO: In Whom, When, and How?
     Circulation. 2023;147:1237-1250.
     

     >> Share

     
     
162. O'DONOGHUE ML, Giugliano RP, Sabatine MS
     Response by O'Donoghue et al to Letter Regarding Article, "Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease".
     Circulation. 2023;147:1258-1259.
     

     >> Share

     
     
163. ZHOU X, Sun P, Yang Q
     Letter by Zhou et al Regarding Article, "Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease".
     Circulation. 2023;147:1256-1257.
     

     >> Share

     
     
164. PARLOW S, Di Santo P, Abdel-Razek O, Jung RG, et al
     Utility of a Smartphone Application in Assessing Palmar Circulation Before Radial Artery Harvesting for Coronary Artery Bypass Grafting.
     Circulation. 2023;147:1183-1185.
     

     >> Share

     
     
165. MA H, Wang X, Xue Q, Li X, et al
     Cardiovascular Health and Life Expectancy Among Adults in the United States.
     Circulation. 2023;147:1137-1146.
     

     >> Share

     
     
166. MEHTA LS, Velarde GP, Lewey J, Sharma G, et al
     Cardiovascular Disease Risk Factors in Women: The Impact of Race and Ethnicity: A Scientific Statement From the American Heart Association.
     Circulation. 2023 Apr 10. doi: 10.1161/CIR.0000000000001139.
     

     >> Share

     
     
167. AKL E, Sniderman AD
     Cholesterol, Coronary Calcification, and Cardiovascular Prevention: Lessons We Can Learn From the Western Denmark Heart Registry.
     Circulation. 2023;147:1064-1066.
     

     >> Share

     
     
168. PEREZ DE ISLA L, Diaz-Diaz JL, Romero MJ, Muniz-Grijalvo O, et al
     Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study.
     Circulation. 2023 Apr 3. doi: 10.1161/CIRCULATIONAHA.122.062557.
     

     >> Share

     
     March 2023
169. CAI W, Liu L, Shi X, Liu Y, et al
     Alox15/15-HpETE Aggravates Myocardial Ischemia-Reperfusion Injury by Promoting Cardiomyocyte Ferroptosis.
     Circulation. 2023 Mar 29. doi: 10.1161/CIRCULATIONAHA.122.060257.
     

     >> Share

     
     
170. SIPILA PN, Lindbohm JV, David Batty G, Heikkila N, et al
     Severe Infection and Risk of Cardiovascular Disease: A Multicohort Study.
     Circulation. 2023 Mar 27. doi: 10.1161/CIRCULATIONAHA.122.061183.
     

     >> Share

     
     
171. DAVENPORT MS, Perazella MA, Nallamothu BK
     Contrast-Induced Acute Kidney Injury and Cardiovascular Imaging: Danger or Distraction?
     Circulation. 2023;147:847-849.
     

     >> Share

     
     
172. 
     Expression of Concern: c-Cbl Inhibition Improves Cardiac Function and Survival in Response to Myocardial Ischemia.
     Circulation. 2023 Mar 13. doi: 10.1161/CIR.0000000000001144.
     

     >> Share

     
     
173. MENG Z, Zhang Z, Zhao J, Liu C, et al
     Nitrative Modification of Caveolin-3: A Novel Mechanism of Cardiac Insulin Resistance and a Potential Therapeutic Target Against Ischemic Heart Failure in Prediabetic Animals.
     Circulation. 2023 Mar 8. doi: 10.1161/CIRCULATIONAHA.122.063073.
     

     >> Share

     
     
174. PARKHOMENKO A
     Russia's War in Ukraine and Cardiovascular Health Care.
     Circulation. 2023;147:779-781.
     

     >> Share

     
     
175. VERMA S, Alamuddin N, Alawadi F, Alkandari H, et al
     Prevalence of Diabetes and Cardiovascular Risk in the Middle East and Africa: Primary Results of the PACT-MEA Study.
     Circulation. 2023 Mar 6. doi: 10.1161/CIRCULATIONAHA.123.064345.
     

     >> Share

     
     
176. HAN JK, Hwang D, Yang S, Park SH, et al
     Comparison Of 3-6 Month Versus 12 Month Dual Antiplatelet Therapy After Coronary Intervention Using the Contemporary Drug-eluting Stents With Ultrathin Struts: The HOST-IDEA Randomized Clinical Trial.
     Circulation. 2023 Mar 5. doi: 10.1161/CIRCULATIONAHA.123.064264.
     

     >> Share

     
     
177. CAMPBELL DJT, Mitchell C, Hemmelgarn BR, Tonelli M, et al
     Eliminating Medication Copayments for Low-income Older Adults at High Cardiovascular Risk: A Randomized Controlled Trial.
     Circulation. 2023 Mar 5. doi: 10.1161/CIRCULATIONAHA.123.064188.
     

     >> Share

     
     
178. VIRANI SS, Ramsey DJ, Westerman D, Kuebeler MK, et al
     Cluster Randomized Trial Of A Personalized Clinical Decision Support Intervention To Improve Statin Prescribing In Patients With Atherosclerotic Cardiovascular Disease (PCDS Statin).
     Circulation. 2023 Mar 5. doi: 10.1161/CIRCULATIONAHA.123.064226.
     

     >> Share

     
     
179. MODIN D, Johansen ND, Vaduganathan M, Bhatt AS, et al
     The Effect of Electronic Nudges on Influenza Vaccination Rate in Older Adults With Cardiovascular Disease: a Prespecified Analysis of the NUDGE-FLU Trial.
     Circulation. 2023 Mar 5. doi: 10.1161/CIRCULATIONAHA.123.064270.
     

     >> Share

     
     
180. CAMPBELL DJT, Tonelli M, Hemmelgarn BR, Faris P, et al
     Self-management Support Using Advertising Principles for Older Low Income Adults at High Cardiovascular Risk: a Randomized Controlled Trial.
     Circulation. 2023 Mar 5. doi: 10.1161/CIRCULATIONAHA.123.064189.
     

     >> Share

     
     
181. YANG J, Shan D, Wang X, Sun X, et al
     On-Site Computed Tomography-Derived Fractional Flow Reserve to Guide the Management of Patients with Stable Coronary Artery Disease: the TARGET Randomized Trial.
     Circulation. 2023 Mar 4. doi: 10.1161/CIRCULATIONAHA.123.063996.
     

     >> Share

     
     February 2023
182. RAZAVI AC, Walden LI, Sperling LS
     Lessons in Cardiovascular Disease Prevention from Number 42: The Told and Untold Stories of Jackie Robinson.
     Circulation. 2023 Feb 28. doi: 10.1161/CIRCULATIONAHA.123.063976.
     

     >> Share

     
     
183. JOSHI PH, Nasir K, Navar AM
     When Opportunity Knocks: Capitalizing on Incidental Coronary Arterial Calcification.
     Circulation. 2023;147:715-717.
     

     >> Share

     
     
184. 
     Correction to: Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction With Nonobstructive Coronary Arteries in Women.
     Circulation. 2023;147:e624.
     

     >> Share

     
     
185. GERSTEIN HC, Li Z, Ramasundarahettige C, Baek S, et al
     Exploring the Relationship Between Efpeglenatide Dose and Cardiovascular Outcomes in Type 2 Diabetes: Insights From the AMPLITUDE-O Trial.
     Circulation. 2023 Feb 20. doi: 10.1161/CIRCULATIONAHA.122.063716.
     

     >> Share

     
     
186. LUU JM, Malhotra P, Cook-Wiens G, Pepine CJ, et al
     Long-Term Adverse Outcomes in Black Women With Ischemia and No Obstructive Coronary Artery Disease: A Study of the WISE (Women's Ischemia Syndrome Evaluation) Cohort.
     Circulation. 2023;147:617-619.
     

     >> Share

     
     
187. COUGHLAN JJ, Raber L, Brugaletta S, Kufner S, et al
     Sex Differences in 10-Year Outcomes After Percutaneous Coronary Intervention With Drug-Eluting Stents: Insights From the DECADE Cooperation.
     Circulation. 2023;147:575-585.
     

     >> Share

     
     
188. KHAN SS, Brewer LC, Canobbio MM, Cipolla MJ, et al
     Optimizing Prepregnancy Cardiovascular Health to Improve Outcomes in Pregnant and Postpartum Individuals and Offspring: A Scientific Statement From the American Heart Association.
     Circulation. 2023;147:e76-e91.
     

     >> Share

     
     
189. BEACH LB, Streed CG Jr
     Beyond Sex-Based Medicine in Cardiovascular Health Research and Practice.
     Circulation. 2023;147:529-531.
     

     >> Share

     
     
190. RODRIGUEZ F
     Sex Disparities in Prevention of Atherosclerotic Cardiovascular Disease Across the Life Course.
     Circulation. 2023;147:523-525.
     

     >> Share

     
     
191. MENG ML, Arendt KW, Banayan JM, Bradley EA, et al
     Anesthetic Care of the Pregnant Patient With Cardiovascular Disease: A Scientific Statement From the American Heart Association.
     Circulation. 2023 Feb 13. doi: 10.1161/CIR.0000000000001121.
     

     >> Share

     
     
192. GABA P, O'Donoghue ML, Park JG, Wiviott SD, et al
     Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE.
     Circulation. 2023 Feb 13. doi: 10.1161/CIRCULATIONAHA.122.063399.
     

     >> Share

     
     
193. HENRY TD, Yannopoulos D, van Diepen S
     Extracorporeal Membrane Oxygenation for Cardiogenic Shock: When to Open the Parachute?
     Circulation. 2023;147:465-468.
     

     >> Share

     
     
194. OSTADAL P, Rokyta R, Karasek J, Kruger A, et al
     Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Results of the ECMO-CS Randomized Clinical Trial.
     Circulation. 2023;147:454-464.
     

     >> Share

     
     
195. SHEN M, Liu C, Zhao SR, Manhas A, et al
     Stepwise Generation of Human Induced Pluripotent Stem Cell-Derived Cardiac Pericytes to Model Coronary Microvascular Dysfunction.
     Circulation. 2023;147:515-518.
     

     >> Share

     
     January 2023
196. BULARGA A, Ken Lee K, Shah ASV, Anand A, et al
     Impact of Patient Selection on Performance of an Early Rule-Out Pathway for Myocardial Infarction: From Research to the Real World.
     Circulation. 2023;147:447-449.
     

     >> Share

     
     
197. STUBER M, Baggish AL
     Acute Myocardial Injury in the COVID-HEART Study: Emphasizing Scars While Reassuring Scares.
     Circulation. 2023;147:375-377.
     

     >> Share

     
     
198. DIMOPOULOS K, Constantine A, Clift P, Condliffe R, et al
     Cardiovascular Complications of Down Syndrome: Scoping Review and Expert Consensus.
     Circulation. 2023;147:425-441.
     

     >> Share

     
     
199. VLASSCHAERT C, Heimlich JB, Rauh MJ, Natarajan P, et al
     Interleukin-6 Receptor Polymorphism Attenuates Clonal Hematopoiesis-Mediated Coronary Artery Disease Risk Among 451 180 Individuals in the UK Biobank.
     Circulation. 2023;147:358-360.
     

     >> Share

     
     
200. RIGAUD VOC, Hoy RC, Kurian J, Zarka C, et al
     RNA-Binding Protein LIN28a Regulates New Myocyte Formation in the Heart Through Long Noncoding RNA-H19.
     Circulation. 2023;147:324-337.
     

     >> Share

     
     
201. LAWLER PR
     Models for Evidence Generation During the COVID-19 Pandemic: New Opportunities for Clinical Trials in Cardiovascular Medicine.
     Circulation. 2023;147:187-189.
     

     >> Share

     
     
202. POWELL-WILEY TM
     Centering Patient Voices Through Community Engagement in Cardiovascular Research.
     Circulation. 2023;147:105-107.
     

     >> Share

     
     
203. CAPODANNO D, Angiolillo DJ
     Long-Term P2Y(12) Inhibitor or Aspirin as Single Antiplatelet Therapy in Patients With Previous Percutaneous Coronary Intervention.
     Circulation. 2023;147:118-121.
     

     >> Share

     
     
204. MORTENSEN MB, Dzaye O, Botker HE, Jensen JM, et al
     Low-Density Lipoprotein Cholesterol Is Predominantly Associated With Atherosclerotic Cardiovascular Disease Events in Patients With Evidence of Coronary Atherosclerosis: The Western Denmark Heart Registry.
     Circulation. 2023 Jan 9. doi: 10.1161/CIRCULATIONAHA.122.061010.
     

     >> Share

     
     
205. AENGEVAEREN VL, Mosterd A, Bakker EA, Braber TL, et al
     Exercise Volume Versus Intensity and the Progression of Coronary Atherosclerosis in Middle-Aged and Older Athletes: Findings From the MARC-2 Study.
     Circulation. 2023 Jan 4. doi: 10.1161/CIRCULATIONAHA.122.061173.
     

     >> Share

     
     
206. NTSEKHE M, Baker JV
     Cardiovascular Disease Among Persons Living With HIV: New Insights Into Pathogenesis and Clinical Manifestations in a Global Context.
     Circulation. 2023;147:83-100.
     

     >> Share

     
     
207. WESTCOTT SK, Lewis TT, Albert MA
     Tackling Adversity and Cardiovascular Health: It is About Time.
     Circulation. 2023;147:e1-e3.
     

     >> Share

     
     
208. BRADLEY SM, Gluckman TJ
     If the Fates Allow: The Zero-Sum Game of ISCHEMIA-EXTEND.
     Circulation. 2023;147:20-22.
     

     >> Share

     
     December 2022
209. CHENG YY, Gregorich Z, Prajnamitra RP, Lundy DJ, et al
     Metabolic Changes Associated With Cardiomyocyte Dedifferentiation Enable Adult Mammalian Cardiac Regeneration.
     Circulation. 2022;146:1950-1967.
     

     >> Share

     
     
210. PALUCH AE, Bajpai S, Ballin M, Bassett DR, et al
     Prospective Association of Daily Steps With Cardiovascular Disease: A Harmonized Meta-Analysis.
     Circulation. 2022 Dec 20. doi: 10.1161/CIRCULATIONAHA.122.061288.
     

     >> Share

     
     
211. GYLDENKERNE C, Maeng M, Kjoller-Hansen L, Maehara A, et al
     Coronary Artery Lesion Lipid Content and Plaque Burden in Diabetic and Nondiabetic Patients: PROSPECT II.
     Circulation. 2022 Dec 16. doi: 10.1161/CIRCULATIONAHA.122.061983.
     

     >> Share

     
     
212. MARK ESTES NA, Jain S, Saba S
     Coronary Vasospasm With Pulse Field Ablation: Primum Non Nocere.
     Circulation. 2022;146:1820-1822.
     

     >> Share

     
     
213. MARX N, Husain M, Lehrke M, Verma S, et al
     GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes.
     Circulation. 2022;146:1882-1894.
     

     >> Share

     
     
214. TANI H, Sadahiro T, Yamada Y, Isomi M, et al
     Direct Reprogramming Improves Cardiac Function and Reverses Fibrosis in Chronic Myocardial Infarction.
     Circulation. 2022 Dec 12. doi: 10.1161/CIRCULATIONAHA.121.058655.
     

     >> Share

     
     
215. DAMLUJI AA, Forman DE, Wang TY, Chikwe J, et al
     Management of Acute Coronary Syndrome in the Older Adult Population: A Scientific Statement From the American Heart Association.
     Circulation. 2022 Dec 12. doi: 10.1161/CIR.0000000000001112.
     

     >> Share

     
     
216. ALAHMAD B, Khraishah H, Roye D, Vicedo-Cabrera AM, et al
     Associations Between Extreme Temperatures and Cardiovascular Cause-Specific Mortality: Results From 27 Countries.
     Circulation. 2022 Dec 12. doi: 10.1161/CIRCULATIONAHA.122.061832.
     

     >> Share

     
     
217. MASURKAR N, Bouvet M, Logeart D, Jouve C, et al
     Novel Cardiokine GDF3 Predicts Adverse Fibrotic Remodeling After Myocardial Infarction.
     Circulation. 2022 Dec 9. doi: 10.1161/CIRCULATIONAHA.121.056272.
     

     >> Share

     
     
218. 
     Correction to: A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction.
     Circulation. 2022;146:e330.
     

     >> Share

     
     November 2022
219. FIGTREE GA, Adamson PD, Antoniades C, Blumenthal RS, et al
     Noninvasive Plaque Imaging to Accelerate Coronary Artery Disease Drug Development.
     Circulation. 2022;146:1712-1727.
     

     >> Share

     
     
220. RAITAKARI O, Kartiosuo N, Pahkala K, Hutri-Kahonen N, et al
     Lipoprotein(a) in Youth and Prediction of Major Cardiovascular Outcomes in Adulthood.
     Circulation. 2022 Nov 28. doi: 10.1161/CIRCULATIONAHA.122.060667.
     

     >> Share

     
     
221. MOSARLA RC, Secemsky EA
     From IMPERIALism to EMINENence: The Noble Rise of the Second-Generation Peripheral Drug-Eluting Stent.
     Circulation. 2022;146:1577-1580.
     

     >> Share

     
     
222. TONELLI M, Straus S
     Increasing Societal Benefit From Cardiovascular Drugs.
     Circulation. 2022;146:1627-1635.
     

     >> Share

     
     
223. STEG PG, Kikoine J
     Do We Need Ischemia Testing to Monitor Asymptomatic Patients With Chronic Coronary Syndromes?
     Circulation. 2022 Nov 16. doi: 10.1161/CIRCULATIONAHA.122.053565.
     

     >> Share

     
     
224. ZHANG S, Liu S, Leach JP, Li K, et al
     Gene Therapy Knockdown of Hippo Signaling Resolves Arrhythmic Events in Pigs After Myocardial Infarction.
     Circulation. 2022;146:1558-1560.
     

     >> Share

     
     
225. 
     Correction to: Status of Cardiovascular Health in US Adults and Children Using the American Heart Association's New "Life's Essential 8" Metrics: Prevalence Estimates From the National Health and Nutrition Examination Survey (NHANES), 2013 Through 201
     Circulation. 2022;146:e298.
     

     >> Share

     
     
226. TAKAHASHI EA, Schwamm LH, Adeoye OM, Alabi O, et al
     An Overview of Telehealth in the Management of Cardiovascular Disease: A Scientific Statement From the American Heart Association.
     Circulation. 2022 Nov 14. doi: 10.1161/CIR.0000000000001107.
     

     >> Share

     
     
227. AGIRBASLI M, Aksoy A
     Letter by Agirbasli and Aksoy Regarding Article, "Coronary Artery and Cardiac Disease in Patients With Type 2 Myocardial Infarction: A Prospective Cohort Study".
     Circulation. 2022;146:e257.
     

     >> Share

     
     
228. BULARGA A, Mills NL, Chapman AR
     Response by Bularga et al to Letter Regarding Article, "Coronary Artery and Cardiac Disease in Patients With Type 2 Myocardial Infarction: A Prospective Cohort Study".
     Circulation. 2022;146:e258-e259.
     

     >> Share

     
     
229. SANDHU AT, Rodriguez F, Ngo S, Patel BN, et al
     Incidental Coronary Artery Calcium: Opportunistic Screening of Prior Non-gated Chest CTs to Improve Statin Rates (NOTIFY-1 Project).
     Circulation. 2022 Nov 7. doi: 10.1161/CIRCULATIONAHA.122.062746.
     

     >> Share

     
     
230. KANG J, Park KW, Lee H, Hwang D, et al
     Aspirin vs. Clopidogrel for Chronic Maintenance Monotherapy after Percutaneous Coronary Intervention: the HOST-EXAM Extended Study.
     Circulation. 2022 Nov 7. doi: 10.1161/CIRCULATIONAHA.122.062770.
     

     >> Share

     
     
231. HOCHMAN JS, Anthopolos R, Reynolds HR, Bangalore S, et al
     Survival After Invasive or Conservative Management of Stable Coronary Disease.
     Circulation. 2022 Nov 6. doi: 10.1161/CIRCULATIONAHA.122.062714.
     

     >> Share

     
     
232. WU H, Xu L, Zhao X, Zhang H, et al
     Indobufen or Aspirin on Top of Clopidogrel after Coronary Drug-eluting Stent Implantation (OPTION): a Randomized, Open-label, Endpoint-blinded, Non-inferiority Trial.
     Circulation. 2022 Nov 6. doi: 10.1161/CIRCULATIONAHA.122.062762.
     

     >> Share

     
     
233. REINECKE H, Engelbertz C, Bauersachs R, Breithardt G, et al
     A Randomized Controlled Trial Comparing Apixaban to the Vitamin K-antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 study.
     Circulation. 2022 Nov 6. doi: 10.1161/CIRCULATIONAHA.122.062779.
     

     >> Share

     
     
234. SHAH NS, Huang X, Petito LC, Bancks MP, et al
     Social and Psychosocial Determinants of Racial and Ethnic Differences in Cardiovascular Health in the United States Population.
     Circulation. 2022 Nov 5. doi: 10.1161/CIRCULATIONAHA.122.061991.
     

     >> Share

     
     
235. WYCKOFF MH, Greif R, Morley PT, Ng KC, et al
     2022 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Educatio
     Circulation. 2022 Nov 3. doi: 10.1161/CIR.0000000000001095.
     

     >> Share

     
     
236. MEHRAN R, Steg PG, Pfeffer MA, Jering K, et al
     The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial.
     Circulation. 2022 Nov 2. doi: 10.1161/CIRCULATIONAHA.122.060841.
     

     >> Share

     
     
237. AIRAKSINEN KEJ, Aalto R, Hellman T, Vasankari T, et al
     Novel Troponin Fragmentation Assay to Discriminate Between Troponin Elevations in Acute Myocardial Infarction and End-Stage Renal Disease.
     Circulation. 2022;146:1408-1410.
     

     >> Share

     
     October 2022
238. APPLE FS, Smith SW, Greenslade JH, Sandoval Y, et al
     Single High-Sensitivity Point of Care Whole Blood Cardiac Troponin I Measurement to Rule Out Acute Myocardial Infarction at Low Risk.
     Circulation. 2022 Oct 31. doi: 10.1161/CIRCULATIONAHA.122.061148.
     

     >> Share

     
     
239. GAZIANO L, Sun L, Arnold M, Bell S, et al
     Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses.
     Circulation. 2022 Oct 31. doi: 10.1161/CIRCULATIONAHA.122.060700.
     

     >> Share

     
     
240. INOUE K, Seeman TE, Horwich T, Budoff MJ, et al
     Heterogeneity in the Association Between the Presence of Coronary Artery Calcium and Cardiovascular Events: A Machine Learning Approach in the MESA Study.
     Circulation. 2022 Oct 31. doi: 10.1161/CIRCULATIONAHA.122.062626.
     

     >> Share

     
     
241. RUEL M, Williams A
     A New Effect Modifier of the Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention Decision: Physical and Mental Functioning.
     Circulation. 2022;146:1281-1283.
     

     >> Share

     
     
242. GOLDMAN S, McCarren M, Sethi GK, Holman W, et al
     Long-Term Mortality Follow-Up of Radial Artery Versus Saphenous Vein in Coronary Artery Bypass Grafting: A Multicenter, Randomized Trial.
     Circulation. 2022;146:1323-1325.
     

     >> Share

     
     
243. GUE YX, Gorog DA, Lip GYH
     Factor XIa Inhibition: Is It a Novel Alternative Antithrombotic Strategy for High-Risk ACS Patients?
     Circulation. 2022;146:1207-1209.
     

     >> Share

     
     
244. GOUEFFIC Y, Torsello G, Zeller T, Esposito G, et al
     Efficacy of a Drug-Eluting Stent Versus Bare Metal Stents for Symptomatic Femoropopliteal Peripheral Artery Disease: Primary Results of the EMINENT Randomized Trial.
     Circulation. 2022 Oct 18:101161CIRCULATIONAHA122059606.
     

     >> Share

     
     
245. CHENG XS, VanWagner LB, Costa SP, Axelrod DA, et al
     Emerging Evidence on Coronary Heart Disease Screening in Kidney and Liver Transplantation Candidates: A Scientific Statement From the American Heart Association.
     Circulation. 2022 Oct 17. doi: 10.1161/CIR.0000000000001104.
     

     >> Share

     
     
246. GIANNITSIS E, Katus HA, Frey N
     Letter by Giannitsis et al Regarding Article, "Skeletal Muscle Disorders: A Noncardiac Source of Cardiac Troponin T".
     Circulation. 2022;146:e202-e203.
     

     >> Share

     
     
247. MOISE N, Cene CW, Tabak RG, Young DR, et al
     Leveraging Implementation Science for Cardiovascular Health Equity: A Scientific Statement From the American Heart Association.
     Circulation. 2022 Oct 10:101161CIR0000000000001096.
     

     >> Share

     
     September 2022
248. REDDY VY, Petru J, Funasako M, Kopriva K, et al
     Coronary Arterial Spasm During Pulsed Field Ablation to Treat Atrial Fibrillation.
     Circulation. 2022 Sep 22:101161CIRCULATIONAHA122061497.
     

     >> Share

     
     
249. ZHANG Q, Burrage MK, Shanmuganathan M, Gonzales RA, et al
     Artificial Intelligence for Contrast-free MRI: Scar Assessment in Myocardial Infarction Using Deep Learning-based Virtual Native Enhancement (VNE).
     Circulation. 2022 Sep 20. doi: 10.1161/CIRCULATIONAHA.122.060137.
     

     >> Share

     
     
250. HOU L, Xie M, Zhao G
     Letter by Hou et al Regarding Article, "MicroRNA-210 Controls Mitochondrial Metabolism and Protects Heart Function in Myocardial Infarction".
     Circulation. 2022;146:e169.
     

     >> Share

     
     
251. DE D, Fu F, Ding M
     Letter by De et al Regarding Article, "MicroRNA-210 Controls Mitochondrial Metabolism and Protects Heart Function in Myocardial Infarction".
     Circulation. 2022;146:e170.
     

     >> Share

     
     
252. SONG R, Zhang L
     Response by Song and Zhang to Letters Regarding Article, "MicroRNA-210 Controls Mitochondrial Metabolism and Protects Heart Function in Myocardial Infarction".
     Circulation. 2022;146:e171-e172.
     

     >> Share

     
     
253. O'DONNELL CJ, Bradner JE
     Bridging the Gap to Translating Genome-Wide Discoveries Into Therapies to Prevent and Treat Atherosclerotic Cardiovascular Disease.
     Circulation. 2022;146:930-933.
     

     >> Share

     
     
254. AHN JM, Kang DY, Yun SC, Hur SH, et al
     Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Artery Disease: Extended Follow-up Outcomes of Multicenter Randomized Controlled BEST Trial.
     Circulation. 2022 Sep 19. doi: 10.1161/CIRCULATIONAHA.122.062188.
     

     >> Share

     
     
255. BRADLEY EA, Winchester D, Alfonso CE, Carpenter AJ, et al
     Physician Wellness in Academic Cardiovascular Medicine: A Scientific Statement From the American Heart Association.
     Circulation. 2022 Sep 19:101161CIR0000000000001093.
     

     >> Share

     
     
256. LOWRY MTH, Doudesis D, Wereski R, Kimenai DM, et al
     Influence of Age on the Diagnosis of Myocardial Infarction.
     Circulation. 2022 Sep 15:101161CIRCULATIONAHA122059994.
     

     >> Share

     
     
257. SHAH AM, Claggett B, Prasad N, Li G, et al
     Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic Substudy.
     Circulation. 2022 Sep 9:101161CIRCULATIONAHA122059210.
     

     >> Share

     
     
258. HADLEY MB, Henderson SB, Brauer M, Vedanthan R, et al
     Protecting Cardiovascular Health From Wildfire Smoke.
     Circulation. 2022;146:788-801.
     

     >> Share

     
     August 2022
259. BONACA MP, Morrow DA, Bergmark BA, Berg DD, et al
     Randomized, Placebo-Controlled Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Lecithin Cholesterol Acyltransferase in Acute ST-Segment-Elevation Myocardial Infarction: Results of REAL-TIMI 63B.
     Circulation. 2022 Aug 30:101161CIRCULATIONAHA122059325.
     

     >> Share

     
     
260. GARGIULO G, Giacoppo D, Jolly SS, Cairns J, et al
     Impact on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: a Meta-analysis of Individual Patient Data from Seven Multicenter Randomized Clinical Trials.
     Circulation. 2022 Aug 29. doi: 10.1161/CIRCULATIONAHA.122.061527.
     

     >> Share

     
     
261. O'DONOGHUE ML, Giugliano RP, Wiviott SD, Atar D, et al
     Long-Term Evolocumab in Patients with Established Atherosclerotic Cardiovascular Disease.
     Circulation. 2022 Aug 29. doi: 10.1161/CIRCULATIONAHA.122.061620.
     

     >> Share

     
     
262. RAO SV, Kirsch B, Bhatt DL, Budaj A, et al
     A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes Following Acute Myocardial Infarction.
     Circulation. 2022 Aug 27. doi: 10.1161/CIRCULATIONAHA.122.061612.
     

     >> Share

     
     
263. GREENLAND P, Maron DJ, Budoff MJ
     Insurance Payers Should Cover Selective Coronary Artery Calcium Testing in Intermediate Risk Primary Prevention Patients.
     Circulation. 2022;146:585-586.
     

     >> Share

     
     
264. JURGENS CY, Lee CS, Aycock DM, Masterson Creber R, et al
     State of the Science: The Relevance of Symptoms in Cardiovascular Disease and Research: A Scientific Statement From the American Heart Association.
     Circulation. 2022 Aug 18:101161CIR0000000000001089.
     

     >> Share

     
     
265. UDELSON JE, Selker HP, Braunwald E
     Glucose-Insulin-Potassium Therapy for Acute Myocardial Infarction: 50 Years On and Time for a Relook.
     Circulation. 2022;146:503-505.
     

     >> Share

     
     
266. SANDOVAL Y, Apple FS, Mahler SA, Body R, et al
     High-Sensitivity Cardiac Troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the Evaluation and Diagnosis of Acute Chest Pain.
     Circulation. 2022;146:569-581.
     

     >> Share

     
     
267. SARNAK MJ, Auguste BL, Brown E, Chang AR, et al
     Cardiovascular Effects of Home Dialysis Therapies: A Scientific Statement From the American Heart Association.
     Circulation. 2022 Aug 15:101161CIR0000000000001088.
     

     >> Share

     
     
268. STABLES RH, Mullen LJ, Elguindy M, Nicholas Z, et al
     Routine Pressure Wire Assessment Versus Conventional Angiography in the Management of Patients With Coronary Artery Disease: The RIPCORD 2 Trial.
     Circulation. 2022 Aug 10:101161CIRCULATIONAHA121057793.
     

     >> Share

     
     
269. GELLER BJ, Sinha SS, Kapur NK, Bakitas M, et al
     Escalating and De-escalating Temporary Mechanical Circulatory Support in Cardiogenic Shock: A Scientific Statement From the American Heart Association.
     Circulation. 2022;146:e50-e68.
     

     >> Share

     
     
270. BERWANGER O, Santo K
     Cardiovascular Care in Brazil: Current Status, Challenges, and Opportunities.
     Circulation. 2022;146:435-437.
     

     >> Share

     
     July 2022
271. KHAN SS, Page C, Wojdyla DM, Schwartz YY, et al
     Predictive Utility of a Validated Polygenic Risk Score for Long-Term Risk of Coronary Heart Disease in Young and Middle-Aged Adults.
     Circulation. 2022 Jul 26:101161CIRCULATIONAHA121058426.
     

     >> Share

     
     
272. MAGNANI JW, Brewer LC
     Leaving the Social Vacuum: Expanding Cardiovascular Guidelines to Embrace Equity.
     Circulation. 2022;146:156-158.
     

     >> Share

     
     
273. KYALWAZI AN, Loccoh EC, Brewer LC, Ofili EO, et al
     Disparities in Cardiovascular Mortality Between Black and White Adults in the United States, 1999 to 2019.
     Circulation. 2022;146:211-228.
     

     >> Share

     
     
274. POST WS, Watson KE, Hansen S, Folsom AR, et al
     Racial and Ethnic Differences in All-Cause and Cardiovascular Disease Mortality: The MESA Study.
     Circulation. 2022;146:229-239.
     

     >> Share

     
     
275. BREWER LC, Jenkins S, Hayes SN, Kumbamu A, et al
     Community-Based, Cluster-Randomized Pilot Trial of a Cardiovascular Mobile Health Intervention: Preliminary Findings of the FAITH! Trial.
     Circulation. 2022;146:175-190.
     

     >> Share

     
     
276. O'SULLIVAN JW, Raghavan S, Marquez-Luna C, Luzum JA, et al
     Polygenic Risk Scores for Cardiovascular Disease: A Scientific Statement From the American Heart Association.
     Circulation. 2022 Jul 18:101161CIR0000000000001077.
     

     >> Share

     
     
277. ONO M, Serruys PW, Garg S, Kawashima H, et al
     Effect of Patient-Reported Preprocedural Physical and Mental Health on 10-Year Mortality After Percutaneous or Surgical Coronary Revascularization.
     Circulation. 2022 Jul 18:101161CIRCULATIONAHA121057021.
     

     >> Share

     
     
278. NISHIYAMA C, Saito Y, Sakaguchi A, Kaneko M, et al
     Prolonged Myocardial Regenerative Capacity in Neonatal Opossum.
     Circulation. 2022;146:125-139.
     

     >> Share

     
     
279. EICHELMANN F, Sellem L, Wittenbecher C, Jager S, et al
     Deep Lipidomics in Human Plasma: Cardiometabolic Disease Risk and Effect of Dietary Fat Modulation.
     Circulation. 2022;146:21-35.
     

     >> Share

     
     June 2022
280. HAGSTROM E, Steg PG, Szarek M, Bhatt DL, et al
     Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
     Circulation. 2022 Jun 30:101161CIRCULATIONAHA121057807.
     

     >> Share

     
     
281. LLOYD-JONES DM, Ning H, Labarthe D, Brewer L, et al
     Status of Cardiovascular Health in US Adults and Children Using the American Heart Association's New "Life's Essential 8" Metrics: Prevalence Estimates from the National Health and Nutrition Examination Survey (NHANES), 2013-2018.
     Circulation. 2022 Jun 29. doi: 10.1161/CIRCULATIONAHA.122.060911.
     

     >> Share

     
     
282. LLOYD-JONES DM, Allen NB, Anderson CAM, Black T, et al
     Life's Essential 8: Updating and Enhancing the American Heart Association's Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association.
     Circulation. 2022 Jun 29:101161CIR0000000000001078.
     

     >> Share

     
     
283. KIMENAI DM, Pirondini L, Gregson J, Prieto D, et al
     Socioeconomic Deprivation: An Important, Largely Unrecognized Risk Factor in Primary Prevention of Cardiovascular Disease.
     Circulation. 2022 Jun 24:101161CIRCULATIONAHA122060042.
     

     >> Share

     
     
284. SOLOMON CU, McVey DG, Andreadi C, Gong P, et al
     Effects of Coronary Artery Disease-Associated Variants on Vascular Smooth Muscle Cells.
     Circulation. 2022 Jun 23:101161CIRCULATIONAHA121058389.
     

     >> Share

     
     
285. KHATANA SAM, Werner RM, Groeneveld PW
     Association of Extreme Heat and Cardiovascular Mortality in the United States: A County-Level Longitudinal Analysis From 2008 to 2017.
     Circulation. 2022 Jun 21:101161CIRCULATIONAHA122060746.
     

     >> Share

     
     
286. MILLS NL, Pope CA
     Environmental Triggers of Acute Coronary Syndromes.
     Circulation. 2022;145:1761-1763.
     

     >> Share

     
     
287. 
     Correction to: Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity.
     Circulation. 2022 Jun 14:101161CIR0000000000001084.
     

     >> Share

     
     
288. SANDOVAL Y, Lewis BR, Mehta RA, Ola O, et al
     Rapid Exclusion of Acute Myocardial Injury and Infarction With a Single High-Sensitivity Cardiac Troponin T in the Emergency Department: A Multicenter United States Evaluation.
     Circulation. 2022;145:1708-1719.
     

     >> Share

     
     
289. CHAN N, Premawardhana D, Al-Hussaini A, Wood A, et al
     Pregnancy and Spontaneous Coronary Artery Dissection: Lessons From Survivors and Nonsurvivors.
     Circulation. 2022 Jun 3. doi: 10.1161/CIRCULATIONAHA.122.059635.
     

     >> Share

     
     
290. ZHENG Y, Joyce B, Hwang SJ, Ma J, et al
     Association of Cardiovascular Health Through Young Adulthood With Genome-Wide DNA Methylation Patterns in Midlife: The CARDIA Study.
     Circulation. 2022 Jun 2:101161CIRCULATIONAHA121055484.
     

     >> Share

     
     May 2022
291. FEARON WF, Zimmermann FM, Ding VY, Zelis JM, et al
     Quality of Life After Fractional Flow Reserve-Guided PCI Compared With Coronary Bypass Surgery.
     Circulation. 2022;145:1655-1662.
     

     >> Share

     
     
292. ANTHONY C, Imran M, Pouliopoulos J, Emmanuel S, et al
     Cardiovascular Magnetic Resonance for Rejection Surveillance After Cardiac Transplantation.
     Circulation. 2022 May 27:101161CIRCULATIONAHA121057006.
     

     >> Share

     
     
293. SHAH NS, Ning H, Petito LC, Kershaw KN, et al
     Associations of Clinical and Social Risk Factors With Racial Differences in Premature Cardiovascular Disease.
     Circulation. 2022 May 24:101161CIRCULATIONAHA121058311.
     

     >> Share

     
     
294. GOLDBERG RB, Orchard TJ, Crandall JP, Boyko EJ, et al
     Effects of Long-term Metformin and Lifestyle Interventions on Cardiovascular Events in the Diabetes Prevention Program and Its Outcome Study.
     Circulation. 2022 May 23. doi: 10.1161/CIRCULATIONAHA.121.056756.
     

     >> Share

     
     
295. 
     Correction to: Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity.
     Circulation. 2022 May 20:101161CIR0000000000001080.
     

     >> Share

     
     
296. PETEK BJ, Moulson N, Drezner JA, Harmon KG, et al
     Cardiovascular Outcomes in Collegiate Athletes Following SARS-CoV-2 Infection: 1-year Follow-up from the Outcomes Registry for Cardiac Conditions in Athletes.
     Circulation. 2022 May 12. doi: 10.1161/CIRCULATIONAHA.121.058272.
     

     >> Share

     
     
297. CHOW CK, Klimis H, Thiagalingam A, Redfern J, et al
     Text Messages to Improve Medication Adherence and Secondary Prevention After Acute Coronary Syndrome: The TEXTMEDS Randomized Clinical Trial.
     Circulation. 2022;145:1443-1455.
     

     >> Share

     
     
298. NAGAREDDY PR, Sreejit G
     Response by Nagareddy and Sreejit to Letter Regarding Article, "Retention of the NLRP3 Inflammasome-Primed Neutrophils in the Bone Marrow Is Essential for Myocardial Infarction-Induced Granulopoiesis".
     Circulation. 2022;145:e1035-e1036.
     

     >> Share

     
     
299. REN C, Yang Z
     Letter by Ren and Yang Regarding Article, "Retention of the NLRP3 Inflammasome-Primed Neutrophils in the Bone Marrow Is Essential for Myocardial Infarction-Induced Granulopoiesis".
     Circulation. 2022;145:e1034.
     

     >> Share

     
     
300. WENGER NK, Lloyd-Jones DM, Elkind MSV, Fonarow GC, et al
     Call to Action for Cardiovascular Disease in Women: Epidemiology, Awareness, Access, and Delivery of Equitable Health Care: A Presidential Advisory From the American Heart Association.
     Circulation. 2022 May 9:101161CIR0000000000001071.
     

     >> Share

     
     
301. BERLOWITZ JB, Xie W, Harlow AF, Hamburg NM, et al
     E-cigarette Use and Risk of Cardiovascular Disease: A Longitudinal Analysis of the PATH Study, 2013-2019.
     Circulation. 2022 May 6. doi: 10.1161/CIRCULATIONAHA.121.057369.
     

     >> Share

     
     
302. FURTADO RHM, Raz I, Goodrich EL, Murphy SA, et al
     Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure: Observations From DECLARE-TIMI 58 Trial.
     Circulation. 2022 May 5. doi: 10.1161/CIRCULATIONAHA.121.058103.
     

     >> Share

     
     
303. EMOTO T, Yamamoto H, Yamashita T, Takaya T, et al
     Single-Cell RNA Sequencing Reveals a Distinct Immune Landscape of Myeloid Cells in Coronary Culprit Plaques Causing Acute Coronary Syndrome.
     Circulation. 2022;145:1434-1436.
     

     >> Share

     
     April 2022
304. PATEL KK
     Improving Symptoms and Quality of Life in Stable Coronary Artery Disease: An Evolving Paradigm.
     Circulation. 2022;145:1308-1311.
     

     >> Share

     
     
305. BOUCHARD K, Liu PP, Tulloch H
     The Social Robots Are Coming: Preparing for a New Wave of Virtual Care in Cardiovascular Medicine.
     Circulation. 2022;145:1291-1293.
     

     >> Share

     
     
306. CHEN R, Jiang Y, Hu J, Chen H, et al
     Hourly Air Pollutants and Acute Coronary Syndrome Onset In 1.29 Million Patients.
     Circulation. 2022 Apr 22. doi: 10.1161/CIRCULATIONAHA.121.057179.
     

     >> Share

     
     
307. 
     Correction to: Coronary Artery and Cardiac Disease in Patients With Type 2 Myocardial Infarction: A Prospective Cohort Study.
     Circulation. 2022;145:e841.
     

     >> Share

     
     
308. LUSEBRINK E, Kellnar A, Krieg K, Binzenhofer L, et al
     Percutaneous Transvalvular Microaxial Flow Pump Support in Cardiology.
     Circulation. 2022;145:1254-1284.
     

     >> Share

     
     
309. WHITE HD
     Zooming in on the Enigmas of Type 2 Myocardial Infarction.
     Circulation. 2022;145:1201-1204.
     

     >> Share

     
     
310. JIA D, Chen S, Bai P, Luo C, et al
     Cardiac Resident Macrophage-derived Legumain Improves Cardiac Repair via Promoting Clearance and Degradation of Apoptotic Cardiomyocytes after Myocardial Infarction.
     Circulation. 2022 Apr 18. doi: 10.1161/CIRCULATIONAHA.121.057549.
     

     >> Share

     
     
311. VASAN RS, Enserro DM, Xanthakis V, Beiser AS, et al
     Temporal Trends in the Remaining Lifetime Risk of Cardiovascular Disease Among Middle-Aged Adults Across 6 Decades: The Framingham Study.
     Circulation. 2022 Apr 18. doi: 10.1161/CIRCULATIONAHA.121.057889.
     

     >> Share

     
     
312. ZHANG J, Liang R, Wang K, Zhang W, et al
     Novel CaMKII-delta Inhibitor Hesperadin Exerts Dual Functions to Ameliorate Cardiac Ischemia/Reperfusion Injury and Inhibit Tumor Growth.
     Circulation. 2022;145:1154-1168.
     

     >> Share

     
     
313. JONE PN, John A, Oster ME, Allen K, et al
     SARS-CoV-2 Infection and Associated Cardiovascular Manifestations and Complications in Children and Young Adults: A Scientific Statement From the American Heart Association.
     Circulation. 2022 Apr 11:101161CIR0000000000001064.
     

     >> Share

     
     March 2022
314. SINGH T, Khan H, Gamble DT, Scally C, et al
     Takotsubo Syndrome: Pathophysiology, Emerging Concepts, and Clinical Implications.
     Circulation. 2022;145:1002-1019.
     

     >> Share

     
     
315. KUEHN BM
     Higher Risk of Heart Disease Among South Asians Calls for Targeted Interventions.
     Circulation. 2022;145:1020-1021.
     

     >> Share

     
     
316. BULARGA A, Hung J, Daghem M, Stewart S, et al
     Coronary Artery and Cardiac Disease in Patients With Type 2 Myocardial Infarction: A Prospective Cohort Study.
     Circulation. 2022 Mar 28. doi: 10.1161/CIRCULATIONAHA.121.058542.
     

     >> Share

     
     
317. 
     Correction to: Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association.
     Circulation. 2022;145:e775.
     

     >> Share

     
     
318. NG CF, Teoh JYC, Chiu PKF
     Letter by Ng et al Regarding Article, "Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial".
     Circulation. 2022;145:e773-e774.
     

     >> Share

     
     
319. SONG R, Dasgupta C, Mulder C, Zhang L, et al
     MicroRNA-210 Controls Mitochondrial Metabolism and Protects Heart Function in Myocardial Infarction.
     Circulation. 2022 Mar 17. doi: 10.1161/CIRCULATIONAHA.121.056929.
     

     >> Share

     
     
320. 
     Correction to: 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2022;145:e772.
     

     >> Share

     
     
321. 
     Correction to: 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2022;145:e771.
     

     >> Share

     
     
322. MARK DB, Spertus JA, Bigelow R, Anderson S, et al
     Comprehensive Quality of Life Outcomes with Invasive versus Conservative Management of Chronic Coronary Disease in ISCHEMIA.
     Circulation. 2022 Mar 9. doi: 10.1161/CIRCULATIONAHA.121.057363.
     

     >> Share

     
     
323. NAGAREDDY PR, Sreejit G
     Letter by Nagareddy and Sreejit Regarding Article, "Interleukin-1alpha Is a Central Regulator of Leukocyte-Endothelial Adhesion in Myocardial Infarction and in Chronic Kidney Disease".
     Circulation. 2022;145:e762-e763.
     

     >> Share

     
     
324. SCHUNK SJ, Speer T
     Response by Schunk and Speer to the Letter Regarding Article, "Interleukin-1alpha Is a Central Regulator of Leukocyte-Endothelial Adhesion in Myocardial Infarction and in Chronic Kidney Disease".
     Circulation. 2022;145:e764.
     

     >> Share

     
     
325. MAAMARI DJ, Jaffer FA, Khera AV, Fahed AC, et al
     CYP2C19 Genotyping in Anticoagulated Patients After Percutaneous Coronary Intervention: Should It Be Routine?
     Circulation. 2022;145:721-723.
     

     >> Share

     
     
326. FENG G, Bajpai G, Ma P, Koenig A, et al
     CCL17 Aggravates Myocardial Injury by Suppressing Recruitment of Regulatory T Cells.
     Circulation. 2022;145:765-782.
     

     >> Share

     
     
327. KOHLI-LYNCH CN, Lewsey J, Boyd KA, French DD, et al
     Beyond Ten-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease.
     Circulation. 2022 Mar 7. doi: 10.1161/CIRCULATIONAHA.121.057631.
     

     >> Share

     
     
328. 
     Correction to: 2021 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Neonatal Life Support; Education, Implem
     Circulation. 2022;145:e760.
     

     >> Share

     
     
329. LAWLER PR, Hochman JS, Zarychanski R
     What Are Adaptive Platform Clinical Trials and What Role May They Have in Cardiovascular Medicine?
     Circulation. 2022;145:629-632.
     

     >> Share

     
     February 2022
330. OPSTAL TSJ, van Broekhoven A, Fiolet ATL, Mosterd A, et al
     Long-Term Efficacy of Colchicine in Patients With Chronic Coronary Disease: Insights From LoDoCo2.
     Circulation. 2022;145:626-628.
     

     >> Share

     
     
331. INDOLFI C, Esposito G
     Universal Health Care System and Cardiovascular Disease Burden in Italy.
     Circulation. 2022;145:559-561.
     

     >> Share

     
     
332. LAM CSP
     How to Incorporate Sex and Gender Into the Design of Cardiovascular Clinical Trials.
     Circulation. 2022;145:499-501.
     

     >> Share

     
     
333. ANDROULAKIS E, Azzu A, Papagkikas P, Antonopoulos A, et al
     Spontaneous Coronary Artery Dissection: Insights From Cardiac Magnetic Resonance and Extracoronary Arterial Screening.
     Circulation. 2022;145:555-557.
     

     >> Share

     
     
334. LINDLEY KJ
     Call for Action to Address Increasing Maternal Cardiovascular Mortality in the United States: Strategies for Improving Maternal Cardiovascular Care.
     Circulation. 2022;145:502-504.
     

     >> Share

     
     
335. GONZALEZ-JUANATEY JR, Lemesle G, Puymirat E, Ducrocq G, et al
     One-Year Major Cardiovascular Events After Restrictive Versus Liberal Blood Transfusion Strategy in Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Trial.
     Circulation. 2022;145:486-488.
     

     >> Share

     
     
336. MESSERLI FH, Bavishi C, Bangalore S
     Why Are We Still Prescribing Angiotensin-Converting Enzyme Inhibitors?
     Circulation. 2022;145:413-415.
     

     >> Share

     
     
337. GAO P, You M, Li L, Zhang Q, et al
     Salt-Induced Hepatic Inflammatory Memory Contributes to Cardiovascular Damage Through Epigenetic Modulation of SIRT3.
     Circulation. 2022;145:375-391.
     

     >> Share

     
     
338. LLOYD-JONES DM
     The Power of Patient Stories to Inspire Us to Prevent Cardiovascular Disease and Death: Personal Reflections on the AHA's Scientific Sessions 2021.
     Circulation. 2022;145:e143-e145.
     

     >> Share

     
     
339. ENAS EA, Varkey B
     Letter by Enas and Varkey Regarding Article, "Quantifying and Understanding the Higher Risk of Atherosclerotic Cardiovascular Disease Among South Asian Individuals: Results From the UK Biobank Prospective Cohort Study".
     Circulation. 2022;145:e146.
     

     >> Share

     
     
340. PATEL AP, Khera AV
     Response by Patel and Khera to Letter Regarding Article, "Quantifying and Understanding the Higher Risk of Atherosclerotic Cardiovascular Disease Among South Asian Individuals: Results From the UK Biobank Prospective Cohort Study".
     Circulation. 2022;145:e147-e148.
     

     >> Share

     
     January 2022
341. HASBANI NR, Ligthart S, Brown MR, Heath AS, et al
     American Heart Association's Life's Simple 7: Lifestyle Recommendations, Polygenic Risk, and Lifetime Risk of Coronary Heart Disease.
     Circulation. 2022 Jan 31. doi: 10.1161/CIRCULATIONAHA.121.053730.
     

     >> Share

     
     
342. ABOULEISA RRE, Salama ABM, Ou Q, Tang XL, et al
     Transient Cell Cycle Induction in Cardiomyocytes to Treat Subacute Ischemic Heart Failure.
     Circulation. 2022 Jan 21. doi: 10.1161/CIRCULATIONAHA.121.057641.
     

     >> Share

     
     
343. CHEW DS, Cowper PA, Al-Khalidi H, Anstrom KJ, et al
     Cost Effectiveness of Coronary-Artery Bypass Surgery versus Medicine in Ischemic Cardiomyopathy: The STICH Randomized Clinical Trial.
     Circulation. 2022 Jan 19. doi: 10.1161/CIRCULATIONAHA.121.056276.
     

     >> Share

     
     
344. GRUBB KJ, Kirtane AJ
     The Long-Awaited Revascularization Guidelines Are Out: What's In Them?
     Circulation. 2022;145:155-157.
     

     >> Share

     
     
345. DE LEMOS JA, McGuire DK, Hill JA
     Celebrating The Next Generation of Cardiovascular Investigators.
     Circulation. 2022;145:91-93.
     

     >> Share

     
     
346. JOSEPH JJ, Deedwania P, Acharya T, Aguilar D, et al
     Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association.
     Circulation. 2022 Jan 10:CIR0000000000001040. doi: 10.1161/CIR.0000000000001040.
     

     >> Share

     
     
347. DEFTEREOS SG, Beerkens FJ, Shah B, Giannopoulos G, et al
     Colchicine in Cardiovascular Disease: In-Depth Review.
     Circulation. 2022;145:61-78.
     

     >> Share

     
     
348. CHURCHWELL K, Lloyd-Jones DM, Rochat Harris S, Mehta LS, et al
     Policy Change Needed to Improve Maternal Cardiovascular Health.
     Circulation. 2022;145:e1-e3.
     

     >> Share

     
     December 2021
349. KUEHN BM
     Centering Equity in Cardiovascular Care.
     Circulation. 2021;144:2035-2037.
     

     >> Share

     
     
350. LI C, Qu L, Matz AJ, Murphy PA, et al
     AtheroSpectrum Reveals Novel Macrophage Foam Cell gene Signatures Associated with Atherosclerotic Cardiovascular Disease Risk.
     Circulation. 2021 Dec 16. doi: 10.1161/CIRCULATIONAHA.121.054285.
     

     >> Share

     
     
351. LAWTON JS, Tamis-Holland JE, Bangalore S, Bates ER, et al
     2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2021 Dec 9:CIR0000000000001039. doi: 10.1161/CIR.0000000000001039.
     

     >> Share

     
     
352. LAWTON JS, Tamis-Holland JE, Bangalore S, Bates ER, et al
     2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2021 Dec 9:CIR0000000000001038. doi: 10.1161/CIR.0000000000001038.
     

     >> Share

     
     
353. AL RIFAI M, Blaha MJ, Nambi V, Shea SJC, et al
     Determinants of Incident Atherosclerotic Cardiovascular Disease Events Among Those With Absent Coronary Artery Calcium: Multi-Ethnic Study of Atherosclerosis.
     Circulation. 2021 Dec 8. doi: 10.1161/CIRCULATIONAHA.121.056705.
     

     >> Share

     
     
354. CHANG Q, Xu Z, Liu R
     Acute Inferior Wall Myocardial Infarction: What Is the Culprit Artery?
     Circulation. 2021;144:1893-1895.
     

     >> Share

     
     
355. LAMBRAKIS K, Chew DP
     Response by Lambrakis and Chew to Letter Regarding Article, "Late Outcomes of the RAPID-TnT Randomized Controlled Trial: 0/1-Hour High-Sensitivity Troponin T Protocol in Suspected ACS".
     Circulation. 2021;144:e459-e460.
     

     >> Share

     
     
356. CHIANG CH, Chiang CH, Lee CC
     Letter by Chiang et al Regarding Article, "Late Outcomes of the RAPID-TnT Randomized Controlled Trial: 0/1-Hour High-Sensitivity Troponin T Protocol in Suspected ACS".
     Circulation. 2021;144:e457-e458.
     

     >> Share

     
     November 2021
357. KATZ DH, Tahir UA, Bick AG, Pampana A, et al
     Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights into Cardiovascular Disease.
     Circulation. 2021 Nov 24. doi: 10.1161/CIRCULATIONAHA.121.055117.
     

     >> Share

     
     
358. SREEJIT G, Nooti SK, Jaggers RM, Athmanathan B, et al
     Retention of the NLRP3 Inflammasome-primed Neutrophils in the Bone Marrow is Essential for Myocardial Infarction-induced Granulopoiesis.
     Circulation. 2021 Nov 17. doi: 10.1161/CIRCULATIONAHA.121.056019.
     

     >> Share

     
     
359. RAMAN B, Tunnicliffe EM, Chan K, Ariga R, et al
     Association Between Sarcomeric Variants in Hypertrophic Cardiomyopathy and Myocardial Oxygenation: Insights From a Novel Oxygen-Sensitive Cardiovascular Magnetic Resonance Approach.
     Circulation. 2021;144:1656-1658.
     

     >> Share

     
     
360. LAI Y, Zhuang X, Liao X
     Letter by Lai et al Regarding Article, "Cardiovascular Risk Factor Trajectories Since Childhood and Cognitive Performance in Midlife: The Cardiovascular Risk in Young Finns Study".
     Circulation. 2021;144:e307.
     

     >> Share

     
     
361. HAKALA JO, Raitakari OT, Rovio SP
     Response by Hakala et al to Letter Regarding Article, "Cardiovascular Risk Factor Trajectories Since Childhood and Cognitive Performance in Midlife: The Cardiovascular Risk in Young Finns Study".
     Circulation. 2021;144:e308-e309.
     

     >> Share

     
     
362. WYCKOFF MH, Singletary EM, Soar J, Olasveengen TM, et al
     2021 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Neonatal Life Support; Education, Implementation, and T
     Circulation. 2021 Nov 11:CIR0000000000001017. doi: 10.1161/CIR.0000000000001017.
     

     >> Share

     
     
363. ZAHA VG, Hayek SS, Alexander KM, Beckie TM, et al
     Future Perspectives of Cardiovascular Biomarker Utilization in Cancer Survivors: A Scientific Statement From the American Heart Association.
     Circulation. 2021 Nov 10:CIR0000000000001032. doi: 10.1161/CIR.0000000000001032.
     

     >> Share

     
     
364. 
     Correction to: Combined Associations of Changes in Noncombustible Nicotine or Tobacco Product and Combustible Cigarette Use Habits With Subsequent Short-Term Cardiovascular Disease Risk Among South Korean Men: A Nationwide Cohort Study.
     Circulation. 2021;144:e306.
     

     >> Share

     
     
365. TONG DC, Bloom JE, Quinn S, Nasis A, et al
     Colchicine in Patients With Acute Coronary Syndrome: Two-Year Follow-Up of the Australian COPS Randomized Clinical Trial.
     Circulation. 2021;144:1584-1586.
     

     >> Share

     
     
366. SCHAEFER I, Lopez-Ayala P, Mueller C
     Letter by Schaefer et al Regarding Article, "Diagnostic Performance of High-Sensitivity Cardiac Troponin T Strategies and Clinical Variables in a Multisite US Cohort".
     Circulation. 2021;144:e283-e284.
     

     >> Share

     
     
367. ALLEN BR, Christenson RH, Cohen SA, Weaver MT, et al
     Response by Allen et al to Letter Regarding Article, "Diagnostic Performance of High-Sensitivity Cardiac Troponin T Strategies and Clinical Variables in a Multisite US Cohort".
     Circulation. 2021;144:e285-e286.
     

     >> Share

     
     
368. AUER R, Diethelm P, Berthet A
     Heating Tobacco Sticks Instead of Combusting Conventional Cigarettes and Future Heart Attacks: Still Smoke, and Risk.
     Circulation. 2021;144:1539-1542.
     

     >> Share

     
     
369. RUETZLER K, Smilowitz NR, Berger JS, Devereaux PJ, et al
     Diagnosis and Management of Patients With Myocardial Injury After Noncardiac Surgery: A Scientific Statement From the American Heart Association.
     Circulation. 2021;144:e287-e305.
     

     >> Share

     
     
370. LADDU D, Ma J, Kaar J, Ozemek C, et al
     Health Behavior Change Programs in Primary Care and Community Practices for Cardiovascular Disease Prevention and Risk Factor Management Among Midlife and Older Adults: A Scientific Statement From the American Heart Association.
     Circulation. 2021 Nov 4:CIR0000000000001026. doi: 10.1161/CIR.0000000000001026.
     

     >> Share

     
     
371. MICHOS ED, Udell JA
     Am I Getting the Influenza Shot Too?: Influenza Vaccination as Post-Myocardial Infarction Care for the Prevention of Cardiovascular Events and Death.
     Circulation. 2021;144:1485-1488.
     

     >> Share

     
     
372. CHUANG YT, Ueng KC, Tsai CF
     Grouped Beating After Acute Inferior Myocardial Infarction.
     Circulation. 2021;144:1518-1520.
     

     >> Share

     
     
373. LICHTENSTEIN AH, Appel LJ, Vadiveloo M, Hu FB, et al
     2021 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association.
     Circulation. 2021 Nov 2:CIR0000000000001031. doi: 10.1161/CIR.0000000000001031.
     

     >> Share

     
     
374. COWIE MR, Deanfield J
     Cardiovascular Medicine at a Crossroads in the United Kingdom.
     Circulation. 2021;144:1457-1458.
     

     >> Share

     
     
375. MCNALLY EM, Elkind MSV, Benjamin IJ, Chung MK, et al
     Impact of the COVID-19 Pandemic on Cardiovascular Science: Anticipating Problems and Potential Solutions: A Presidential Advisory From the American Heart Association.
     Circulation. 2021 Nov 1:CIR0000000000001027. doi: 10.1161/CIR.0000000000001027.
     

     >> Share

     
     October 2021
376. VERMA S, Bhatt DL, Steg PG, Miller M, et al
     Icosapent Ethyl Reduces Ischemic Events in Patients with a History of Prior Coronary Artery Bypass Grafting: REDUCE-IT CABG.
     Circulation. 2021 Oct 28. doi: 10.1161/CIRCULATIONAHA.121.056290.
     

     >> Share

     
     
377. MAJITHIA A, Bhatt DL, Friedman AN, Miller M, et al
     Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients with Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL.
     Circulation. 2021 Oct 28. doi: 10.1161/CIRCULATIONAHA.121.055560.
     

     >> Share

     
     
378. YAZAKI Y, Nakamura M, Iijima R, Yasuda S, et al
     Clinical Outcomes of Rivaroxaban Monotherapy in Heart Failure Patients With Atrial Fibrillation and Stable Coronary Disease: Insights From the AFIRE Trial.
     Circulation. 2021;144:1449-1451.
     

     >> Share

     
     
379. BRAILLON A
     Letter by Braillon Regarding Article, "Very High Coronary Artery Calcium (>/=1000) and Association With Cardiovascular Disease Events, Non-Cardiovascular Disease Outcomes, and Mortality: Results From MESA".
     Circulation. 2021;144:e274.
     

     >> Share

     
     
380. PENG AW, Dardari ZA, Blaha MJ
     Response by Peng et al to Letter Regarding Article, "Very High Coronary Artery Calcium (>/=1000) and Association With Cardiovascular Disease Events, Non-Cardiovascular Disease Outcomes, and Mortality: Results From MESA".
     Circulation. 2021;144:e275-e276.
     

     >> Share

     
     
381. NEELAND IJ, McGuire DK, Sattar N
     Cardiovascular Outcomes Trials for Weight Loss Interventions: Another Tool for Cardiovascular Prevention?
     Circulation. 2021;144:1359-1361.
     

     >> Share

     
     
382. SANCHEZ-LOPEZ A, Espinos-Estevez C, Gonzalez-Gomez C, Gonzalo P, et al
     Cardiovascular Progerin Suppression and lamin A Restoration Rescues Hutchinson-Gilford Progeria Syndrome.
     Circulation. 2021 Oct 25. doi: 10.1161/CIRCULATIONAHA.121.055313.
     

     >> Share

     
     
383. KRIS-ETHERTON PM, Petersen KS, Despres JP, Anderson CAM, et al
     Strategies for Promotion of a Healthy Lifestyle in Clinical Settings: Pillars of Ideal Cardiovascular Health: A Science Advisory From the American Heart Association.
     Circulation. 2021 Oct 25:CIR0000000000001018. doi: 10.1161/CIR.0000000000001018.
     

     >> Share

     
     
384. ALE-AGHA N, Jakobs P, Goy C, Zurek M, et al
     Mitochondrial Telomerase Reverse Transcriptase Protects from Myocardial Ischemia/reperfusion Injury by Improving Complex I Composition and Function.
     Circulation. 2021 Oct 21. doi: 10.1161/CIRCULATIONAHA.120.051923.
     

     >> Share

     
     
385. 
     Correction to: Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial.
     Circulation. 2021;144:e273.
     

     >> Share

     
     
386. KHAN SU, Javed Z, Lone AN, Dani SS, et al
     Social Vulnerability and Premature Cardiovascular Mortality Among US Counties, 2014 to 2018.
     Circulation. 2021;144:1272-1279.
     

     >> Share

     
     
387. GANGAVELLI A, Morris AA
     Premature Cardiovascular Mortality in the United States: Who Will Protect the Most Vulnerable Among Us?
     Circulation. 2021;144:1280-1283.
     

     >> Share

     
     
388. JACOBS AK, Ali MJ, Best PJ, Bieniarz MC, et al
     Systems of Care for ST-Segment-Elevation Myocardial Infarction: A Policy Statement From the American Heart Association.
     Circulation. 2021 Oct 13:CIR0000000000001025. doi: 10.1161/CIR.0000000000001025.
     

     >> Share

     
     
389. LEE LY, Oldham WM, He H, Wang R, et al
     Interferon-gamma Impairs Human Coronary Artery Endothelial Glucose Metabolism via Tryptophan Catabolism and Activates Fatty Acid Oxidation.
     Circulation. 2021 Oct 12. doi: 10.1161/CIRCULATIONAHA.121.053960.
     

     >> Share

     
     
390. GENCER B, Djousse L, Al-Ramady OT, Cook NR, et al
     Effect of Long-Term Marine Omega-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.
     Circulation. 2021 Oct 6. doi: 10.1161/CIRCULATIONAHA.121.055654.
     

     >> Share

     
     
391. GAUDINO M, Sandner S, Di Giammarco G, Di Franco A, et al
     The Use of Intraoperative Transit Time Flow Measurement for Coronary Artery Bypass Surgery: Systematic Review of the Evidence and Expert Opinion Statements.
     Circulation. 2021;144:1160-1171.
     

     >> Share

     
     
392. RUEL M, Fischbein M
     Introduction to the 2021 Cardiovascular Surgery Themed Issue of Circulation.
     Circulation. 2021;144:1087.
     

     >> Share

     
     
393. CHOI S, Lee K, Park SM
     Combined Associations of Changes in Noncombustible Nicotine or Tobacco Product and Combustible Cigarette Use Habits With Subsequent Short-Term Cardiovascular Disease Risk Among South Korean Men: A Nationwide Cohort Study.
     Circulation. 2021 Oct 4. doi: 10.1161/CIRCULATIONAHA.121.054967.
     

     >> Share

     
     September 2021
394. KEN LEE K, Wereski R, Williams MC, Mills NL, et al
     Population Screening With Coronary Computed Tomography Angiography and the Prevention of Coronary Events.
     Circulation. 2021;144:930-933.
     

     >> Share

     
     
395. REDD MA, Scheuer SE, Saez NJ, Yoshikawa Y, et al
     Therapeutic Inhibition of Acid-Sensing Ion Channel 1a Recovers Heart Function After Ischemia-Reperfusion Injury.
     Circulation. 2021;144:947-960.
     

     >> Share

     
     
396. LOPEZ-AYALA P, Nestelberger T, Boeddinghaus J, Koechlin L, et al
     Novel Criteria for the Observe-Zone of the ESC 0/1h-hs-cTnT Algorithm.
     Circulation. 2021;144:773-787.
     

     >> Share

     
     August 2021
397. XENOGIANNIS I, Zenati M, Bhatt DL, Rao SV, et al
     Saphenous Vein Graft Failure: From Pathophysiology to Prevention and Treatment Strategies.
     Circulation. 2021;144:728-745.
     

     >> Share

     
     
398. RAJENDRAN G, Muthanikkatt AM, Nathan B
     Not All Waves Are Factual.
     Circulation. 2021;144:751-753.
     

     >> Share

     
     
399. WATERS DD, Stone GW
     Usefulness of Angina to Guide Revascularization Decisions.
     Circulation. 2021;144:524-527.
     

     >> Share

     
     
400. MESNIER J, Ducrocq G, Danchin N, Ferrari R, et al
     International Observational Analysis of Evolution and Outcomes of Chronic Stable Angina: The Multinational CLARIFY Study.
     Circulation. 2021;144:512-523.
     

     >> Share

     
     
401. GOLDSTEIN LN, Wu MT, Wells M
     Does This Ischemic Pattern Look Right?
     Circulation. 2021;144:499-501.
     

     >> Share

     
     
402. SANKARDAS MA, Ramakumar V, Farooqui FA
     Of Occlusions, Inclusions, and Exclusions: Time to Reclassify Infarctions?
     Circulation. 2021;144:333-335.
     

     >> Share

     
     July 2021
403. REAL C, Morales T, Viana-Tejedor A
     An Unusual Call From the Urology Ward.
     Circulation. 2021;144:324-327.
     

     >> Share

     
     
404. SRIDHARAN A, Han JK, Feliciano Z
     An Ominous ECG.
     Circulation. 2021;144:246-248.
     

     >> Share

     
     
405. LAMBRAKIS K, Papendick C, French JK, Quinn S, et al
     Late Outcomes of the RAPID-TnT Randomized Controlled Trial: 0/1-Hour High-Sensitivity Troponin T Protocol in Suspected ACS.
     Circulation. 2021;144:113-125.
     

     >> Share

     
     June 2021
406. MEUWESE CL, Kraaijeveld AO, Donker DW
     Letter by Meuwese et al Regarding Article, "Left Ventricular Unloading Is Associated With Lower Mortality in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation: Results From an International, Multicenter Coho
     Circulation. 2021;143:e1022-e1023.
     

     >> Share

     
     
407. SCHRAGE B, Westermann D
     Response by Schrage and Westermann to Letters Regarding Article, "Left Ventricular Unloading Is Associated With Lower Mortality in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation: Results From an Internati
     Circulation. 2021;143:e1024.
     

     >> Share

     
     
408. MEHMOOD M
     Letter by Mehmood Regarding Article, "Left Ventricular Unloading Is Associated With Lower Mortality in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation: Results From an International, Multicenter Cohort Stu
     Circulation. 2021;143:e1021.
     

     >> Share

     
     
409. EDELMAN ER
     Karnovsky's Dictum: The Endothelium Is Good-Looking and Smart.
     Circulation. 2021;143:2166-2168.
     

     >> Share

     
     May 2021
410. ISOMI M, Sadahiro T, Yamakawa H, Fujita R, et al
     Overexpression of Gata4, Mef2c, and Tbx5 Generates Induced Cardiomyocytes Via Direct Reprogramming and Rare Fusion in the Heart.
     Circulation. 2021;143:2123-2125.
     

     >> Share

     
     March 2021
411. CHUZI S, Kuang F, Khan SS
     Hidden in Plain Sight: An Elusive Cause of Cardiogenic Shock.
     Circulation. 2021;143:959-964.
     

     >> Share

     
     February 2021
412. FORTE E, Perkins B, Sintou A, Kalkat HS, et al
     Cross-Priming Dendritic Cells Exacerbate Immunopathology After Ischemic Tissue Damage in the Heart.
     Circulation. 2021;143:821-836.
     

     >> Share

     
     
413. KARABINOS I, Kostaki P, Panagopoulos Z
     Bizarre Downsloping ST Segment Elevation Challenge.
     Circulation. 2021;143:599-601.
     

     >> Share

     
     January 2021
414. BHASIN D, Isser HS, Gupta A
     Chest Pain With ST-Segment Elevation in a Young Woman: A Broken Heart?
     Circulation. 2021;143:197-201.
     

     >> Share

     
     
415. RASANEN M, Sultan I, Paech J, Hemanthakumar KA, et al
     VEGF-B Promotes Endocardium-Derived Coronary Vessel Development and Cardiac Regeneration.
     Circulation. 2021;143:65-77.
     

     >> Share

     
     
416. QI Z, Hu L, Zhang J, Yang W, et al
     PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Enhances Platelet Activation, Thrombosis, and Myocardial Infarct Expansion by Binding to Platelet CD36.
     Circulation. 2021;143:45-61.
     

     >> Share

     
     November 2020
417. REYNOLDS HR, Maehara A, Kwong RY, Sedlak T, et al
     Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of MINOCA in Women.
     Circulation. 2020 Nov 14. doi: 10.1161/CIRCULATIONAHA.120.052008.
     

     >> Share

     
     August 2020
418. LOPES RD, Alexander KP, Stevens SR, Reynolds HR, et al
     Initial Invasive versus Conservative Management of Stable Ischemic Heart Disease Patients with a History of Heart Failure or Left Ventricular Dysfunction: Insights from the ISCHEMIA Trial.
     Circulation. 2020 Aug 29. doi: 10.1161/CIRCULATIONAHA.120.050304.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share